amiodarone has been researched along with Hypothyroidism in 287 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.
Excerpt | Relevance | Reference |
---|---|---|
"The prevalence of thyroid dysfunction in patients with cardiac arrhythmias receiving amiodarone was considerable." | 9.41 | Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis. ( Alimohamadi, Y; Dalvand, S; Johnston, TP; Karimi, L; Moshkani, M; Rahimi-Bashar, F; Sahebkar, A; Vahedian-Azimi, A, 2023) |
"To determine the incidence and predictability of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH) in patients with cardiomyopathy." | 9.13 | Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism. ( Hofmann, A; Holzmannhofer, J; Nawara, C; Ofluoglu, S; Pirich, C; Strohmer, B, 2008) |
"Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies." | 9.12 | Amiodarone-induced thyrotoxicosis. ( Bricaire, L; Groussin, L; Schubert, L, 2021) |
"This is a substudy of a prospective randomized controlled trial (SAFE-Trial) in which amiodarone, sotalol, and placebo for persistent atrial fibrillation were evaluated." | 9.12 | Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. ( Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC, 2007) |
"The clinical efficacy of a low-dosage schedule of amiodarone was tested in 58 patients with severe ventricular arrhythmias refractory to other drug treatments." | 9.05 | Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation. ( , 1984) |
"Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone." | 8.82 | [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]. ( Barta, K; Lorincz, I; Nagy, E; Simkó, J; Szabó, Z; Varga, E, 2004) |
"Amiodarone, a benzofuranic derivative, iodine-rich drug, has been used in pregnancy for either maternal or fetal tachyarrhythmias." | 8.81 | Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
"Pathogenesis, diagnostic procedures and therapy of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH) are briefly discussed." | 8.80 | [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism]. ( Gerber, H; Noth, D, 1999) |
"Amiodarone, an iodine-rich benzofuranic derivative, may often induce hyperthyroidism and hypothyroidism." | 8.79 | [Amiodarone-induced hypothyroidism followed by hyperthyroidism. Apropos of 2 new cases]. ( Kieffer, P; Saraceni, O; Wilhelm, JM, 1996) |
"Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 7.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
" In patients with untreated amiodarone-induced hypothyroidism, but not in the other groups of patients, metformin reduced serum levels of thyrotropin and this effect correlated weakly with its action on insulin sensitivity." | 7.83 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. ( Gilowska, M; Krysiak, R; Okopień, B; Szkróbka, W, 2016) |
"Amiodarone is a di-iodated benzofuran derivative that is commonly used to treat patients with various cardiac arrhythmias." | 7.79 | [A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism]. ( Chae, HB; Cho, YS; Han, JH; Kang, KM; Kim, JS; Lim, JC; Park, SM, 2013) |
"To define the prevalence and incidence of hypothyroidism in a group of CHF outpatients in stable clinical conditions, with particular reference to the role of amiodarone therapy." | 7.78 | Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone. ( Catanzaro, R; Ciccone, MM; Favale, S; Forleo, C; Giagulli, VA; Guastamacchia, E; Guida, P; Iacoviello, M; Licchelli, B; Monzani, F; Puzzovivo, A; Tafaro, E; Triggiani, V, 2012) |
" Laboratory studies revealed cardiogenic ascites coincided with nephrogenic ascites and subclinical amiodarone-induced hypothyroidism." | 7.78 | Development of refractory ascites during amiodarone therapy in a hemodialysis patient with nephrogenic and cardiogenic ascites. ( Chen, JD; Hwang, B; Lin, YF; Wang, JY, 2012) |
"To report a case of postnatal, postoperative amiodarone-induced hypothyroidism in an infant with a congenital heart defect." | 7.77 | Severe amiodarone-induced hypothyroidism in an infant. ( Panagiotopoulos, C; Sanatani, S; Trudel, K, 2011) |
"Amiodarone-induced hypothyroidism (AIH) may occur in patients with or without underlying thyroid disorders." | 7.74 | Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Cosci, C; Dell'Unto, E; Gasperi, M; Lai, A; Martino, E; Sardella, C; Tanda, ML; Tomisti, L, 2008) |
"Amiodarone-induced thyrotoxicosis (AIT) with features consistent with both AIT type I (in which thyroid antibodies and nodular goiter are present) and AIT type II (which is not responsive to thionamide therapy and eventually leads to permanent hypothyroidism)." | 7.74 | Treatment of amiodarone-associated thyrotoxicosis. ( Franklyn, JA; Gammage, MD, 2007) |
"Blood lipid levels were measured in 23 patients with amiodarone associated hypothyroidism (most of them had ischemic heart disease)." | 7.73 | [Lipid blood spectrum in patients with amiodarone associated hypothyroidism. Effect of replacement therapy with L-thyroxine]. ( Bakalov, SA; Golitsyn, SP; Kotkina, TI; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
" Most respondents lived in iodine-sufficient areas and observed that amiodarone-induced hypothyroidism (AIH) is more common than AIT." | 7.73 | Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. ( Albino, CC; Bartalena, L; Diehl, LA; Graf, H; Martino, E; Romaldini, JH; Wiersinga, WM, 2006) |
"Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | 7.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
"In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 7.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
"Amiodarone may induce hyper- or hypothyroidism." | 7.70 | High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment. ( Balestrieri, A; Lai, ME; Loviselli, A; Mandas, A; Mariotti, S; Martino, E; Murenu, S; Sau, F; Vacquer, S; Valentino, L, 1999) |
"Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 7.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
"A comparative study on ventricular electrophysiologic effects of experimental hypothyroidism and chronic oral amiodarone administration was made in canine models, with the application of electrical stimulation and monophasic action potential recording." | 7.69 | Comparison of cardiac electrophysiologic effects of experimental hypothyroidism and chronic oral amiodarone administration in dogs. ( Li, JM; Liu, PM; Tang, Y; Wu, W; Zhang, XM, 1994) |
"We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 7.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
"Amiodarone, an iodine-rich cardiac drug, may induce thyrotoxicosis (AIT), which can occur in patients with preexisting thyroid abnormalities and in subjects with apparently normal thyroid glands." | 7.69 | Serum interleukin-6 in amiodarone-induced thyrotoxicosis. ( Aghini-Lombardi, F; Bartalena, L; Braverman, LE; Brogioni, S; Grasso, L; Martino, E, 1994) |
"Parameters that are assumed to be under direct control by thyroid hormonal state were evaluated in amiodarone-treated, hypo- and hyperthyroid rats." | 7.69 | Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats. ( Gøtzsche, LB; Orskov, H, 1994) |
"Optimal daily levothyroxine (LT4) dosage is reported to be significantly smaller in the elderly with primary hypothyroidism when compared with their younger counterparts." | 7.69 | Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology. ( Kabadi, UM, 1997) |
"Hypothyroidism followed by hyperthyroidism is described in two patients treated by amiodarone." | 7.68 | [Hypothyroidism followed by hyperthyroidism under treatment with amiodarone]. ( Burger, A; Goumaz, MO; Martin-Du Pan, RC; Perrotet, C, 1993) |
" The potent antithyroid drug, potassium perchlorate (KClO4), is used successfully to treat amiodarone-induced thyrotoxicosis, but it is less well known as potential treatment in amiodarone-induced hypothyroidism." | 7.68 | Treatment of amiodarone-induced hypothyroidism with potassium perchlorate. ( Nikkels, RE; Prummel, MF; van Dam, EW; Wiersinga, WM, 1993) |
"In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule." | 7.68 | Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. ( Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M, 1992) |
"Amiodarone-induced thyrotoxicosis (AIT) occurs most frequently in patients with underlying thyroid disease and is generally believed to be due to the iodine contamination of amiodarone and iodine released by the metabolism of the drug." | 7.68 | Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. ( Bianconi, L; Braverman, LE; Gardini, E; Gavaruzzi, G; Minelli, R; Neri, TM; Roti, E; Ugolotti, G, 1992) |
"Five cases are studied in which amiodarone (AM) was given during pregnancy, in two of them also during the breast feeding period, to estimate the risks for adverse effects." | 7.68 | Use of amiodarone during pregnancy. ( de Vijlder, JJ; Plomp, TA; Vulsma, T, 1992) |
"To determine the incidence and predictability and to elucidate the pathogenesis of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH)." | 7.68 | Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. ( Plomp, TA; Trip, MD; Wiersinga, W, 1991) |
"Amiodarone induced hypothyroidism (AIH) is assumed to result from a failure of the thyroid to escape from the inhibitory effect of inorganic iodine on its organification as a consequence of uninhibited iodide trapping." | 7.67 | 24 h-kinetics of iodide uptake in amiodarone induced hypothyroidism. ( Dumont, JE; Sarot, J; Soupart, A; Surmont, DW; Unger, J, 1989) |
"We report a case of a patient with hypothyroidism due to amiodarone." | 7.67 | [Transitory efficacy of potassium perchlorate in hypothyroidism caused by amiodarone]. ( Confalonieri, F; Foresti, V; Parisio, E; Scolari, N; Terenzio, C; Villa, A, 1989) |
"We studied the effect of potassium perchlorate (KClO4) in patients with hypothyroidism due to amiodarone." | 7.67 | Short term administration of potassium perchlorate restores euthyroidism in amiodarone iodine-induced hypothyroidism. ( Aghini-Lombardi, F; Baschieri, L; Braverman, L; Lenziardi, M; Mariotti, S; Martino, E; Morabito, S; Pinchera, A; Safran, M, 1986) |
"A 54-year-old man on regular haemodialysis developed severe amiodarone-induced hypothyroidism after an unusually short latency period." | 7.67 | Severe hypothyroidism induced by amiodarone in a dialysis patient. ( Catalano, C; Costante, G; Enia, G; Maggiore, Q; Zoccali, C, 1987) |
"Amiodarone, an iodine-rich drug widely used for the treatment of cardiac tachyarrhythmias, may induce either hyperthyroidism or hypothyroidism." | 7.67 | Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. ( Aghini-Lombardi, F; Bambini, G; Bartalena, L; Braverman, LE; Ceccarelli, C; Lenziardi, M; Mariotti, S; Martino, E; Pinchera, A; Safran, M, 1987) |
"Amiodarone is a common anti-arrhythmic agent mostly used to treat and prevent different kinds of arrhythmia with several considerable side effects, most commonly on the thyroid gland." | 7.01 | Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis. ( Bondariyan, N; Heidarpour, M; Mohammadi, K; Rezvanian, H; Shafie, D; Vakhshoori, M, 2023) |
"Amiodarone is an iodine-rich drug used to treat cardiac dysrhythmias." | 6.42 | Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. ( Backeljauw, PF; Jackson, WA; Lomenick, JP, 2004) |
"Iodine is an essential element for thyroid hormone synthesis." | 6.41 | Iodine-Induced hypothyroidism. ( Georgopoulos, N; Kyriazopoulou, V; Markou, K; Vagenakis, AG, 2001) |
" A dose-response relationship was observed between the 1-year accumulated amiodarone dose and the subsequent 5-year cumulative incidence of thyroid dysfunction." | 5.91 | Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. ( Ali, SA; Butt, JH; Ersbøll, M; Fosbøl, E; Gustafsson, F; Jøns, C; Kristensen, SL; Køber, L; Mogensen, UM; Rørth, R; Selmer, C; Vinding, NE; Weeke, PE; Westergaard, LM, 2023) |
"BACKGROUND Myxedema coma is an uncommon severe thyroid disorder that is fatal in 25-60% of cases." | 5.56 | Amiodarone-Associated Myxedema Coma. ( Donato, A; Hirani, F; Jayatilaka, S; Zagorski, E, 2020) |
"The prevalence of thyroid dysfunction in patients with cardiac arrhythmias receiving amiodarone was considerable." | 5.41 | Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis. ( Alimohamadi, Y; Dalvand, S; Johnston, TP; Karimi, L; Moshkani, M; Rahimi-Bashar, F; Sahebkar, A; Vahedian-Azimi, A, 2023) |
" However, the use of RAI in euthyroid patients requiring chronic administration of amiodarone (AM) where other antiarrhythmic drugs may lack efficacy is still controversial." | 5.40 | Results of preventive radioiodine therapy in euthyroid patients with history of hyperthyroidism prior to administration of amiodarone with permanent atrial fibrillation--a preliminary study. ( Czarnywojtek, A; Czepczyński, R; Królicki, L; Kwiecińska, B; Miechowicz, I; Płazińska, MT; Ruchała, M; Woliński, K; Zgorzalewicz-Stachowiak, M, 2014) |
"Here, we report a patient with chronic renal failure who developed EPO-resistant anemia after amiodarone treatment for arrhythmia." | 5.35 | Amiodarone-induced hypothyroidism with EPO-resistant anemia in a patient with chronic renal failure. ( Chang, PM; Ng, YY, 2008) |
"Transient hypothyroidism was observed in only two patients (5%) with AIH, though was not observed in TMNG." | 5.35 | Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT). ( Bartkowiak, Z; Czarnywojtek, A; Czepczynski, R; Florek, E; Ruchala, M; Sowinski, J; Szczepanek, E; Wasko, R; Zamyslowska, H; Zgorzalewicz-Stachowiak, M, 2009) |
"Dronedarone was given in Wistar rats (90 mg/kg, once daily (od) for 2 weeks) (DRON), while untreated animals served as controls (CONT)." | 5.33 | Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. ( Cokkinos, DV; Malliopoulou, V; Moraitis, P; Mourouzis, I; Paizis, I; Pantos, C; Sfakianoudis, K; Tzeis, S; Varonos, DD, 2005) |
"Amiodarone (AMD) is an antiarrhythmic drug which contains 37% of iodine." | 5.30 | Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases. ( Berardi, R; Cioni, M; Grosso, S; Morgese, G, 1998) |
"Amiodarone is a widely used antiarrhythmic drug, the mechanisms of action of which remain incompletely understood." | 5.30 | Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes. ( Bosch, RF; Gaspo, R; Li, GR; Nattel, S, 1999) |
"Amiodarone (AMD) is a powerful anti-arrhythmic drug used for the treatment of a wide variety of cardiac arrhythmias and its most striking feature is its high iodine content." | 5.30 | Amiodarone compared with iodine exhibits a potent and persistent inhibitory effect on TSH-stimulated cAMP production in vitro: a possible mechanism to explain amiodarone-induced hypothyroidism. ( Boyages, SC; Pitsiavas, V; Smerdely, P, 1999) |
"Amiodarone is an iodine-rich drug used in the treatment of resistant cardiac arrhythmias." | 5.29 | Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
"Treatment with amiodarone was continued; however, therapy with L-thyroxin was initiated, followed by a complete regression of the goiter." | 5.28 | Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis. ( Ish-Shalom, S; Kaplan, J, 1991) |
"Hypothyroidism was induced with intraperitoneal (i." | 5.28 | Attenuation of class 3 and sinus node effects of amiodarone by experimental hypothyroidism. ( Davies, M; McCans, J; Nattel, S; Talajic, M, 1989) |
"Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance." | 5.27 | Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases. ( Atkinson, AB; Campbell, NP; Ferguson, WR; Geddes, JS; Hawthorne, GC; Postlethwaite, W; Sheridan, B, 1985) |
"Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 5.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
" Electrophysiologic data obtained before and during thyroxine replacement therapy showed that hypothyroidism lengthens the effective refractory period of the atria, AV node, bypass tract and His-Purkinje system (that in the ventricle not being measured); this lengthening resembles the effects of long-term administration of amiodarone." | 5.27 | Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block. ( Brun, S; Gaita, F; Mangiardi, L; Nademanee, K; Presbitero, P; Singh, BN, 1986) |
"To determine the incidence and predictability of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH) in patients with cardiomyopathy." | 5.13 | Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism. ( Hofmann, A; Holzmannhofer, J; Nawara, C; Ofluoglu, S; Pirich, C; Strohmer, B, 2008) |
"Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies." | 5.12 | Amiodarone-induced thyrotoxicosis. ( Bricaire, L; Groussin, L; Schubert, L, 2021) |
"In iodine-induced hyperthyroidism, antithyroid drugs and perchlorate are primarily used to decrease thyroid hormone synthesis and further iodine uptake into the thyroid." | 5.12 | [Iodine-induced thyroid dysfunction]. ( Eilsberger, F; Feldkamp, J; Luster, M, 2021) |
"This is a substudy of a prospective randomized controlled trial (SAFE-Trial) in which amiodarone, sotalol, and placebo for persistent atrial fibrillation were evaluated." | 5.12 | Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. ( Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC, 2007) |
"Thyroid disorders and eye diseases are interrelated through several mechanisms thus, awareness of this relation has a great impact on early diagnosis and treatment." | 5.05 | Thyroid and Eye: Where They Meet in Clinical Practice. ( El-Eshmawy, MM; Shahin, M, 2020) |
"The clinical efficacy of a low-dosage schedule of amiodarone was tested in 58 patients with severe ventricular arrhythmias refractory to other drug treatments." | 5.05 | Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation. ( , 1984) |
"We reported six patients in the age range from two weeks to 14 years, with complex congenital cardiac diseases and severe arrhythmias, who developed amiodarone-induced thyroid dysfunctions: thyrotoxicosis or hypothyroidism or both together." | 5.01 | Amiodarone-induced thyroid dysfunction in the developmental period: prenatally, in childhood, and adolescence - case reports and a review of the literature. ( Furtak, A; Januś, D; Kalicka-Kasperczyk, A; Kordon, Z; Rudziński, A; Starzyk, JB; Wędrychowicz, A; Wójcik, M, 2019) |
"We made a review of available publications in PUBMED referring the amiodaroneinduced thyroid pathology, focusing on the differential diagnosis, made by nuclear medicine tests, of hypothyroidism (AIH) and hyperthyroidism expressed as: type I amiodarone induced thyrotoxicosis (AIT I), type II amiodarone induced thyrotoxicosis (AIT II), and less frequently as a mixt form, type III amiodarone induced thyrotoxicosis (AIT III)." | 4.95 | The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology. ( Irimie, A; Piciu, D, 2017) |
"Amiodarone is an antiarrhythmic agent among the I most powerful and the most frequently used for the control of recurrent ventricular tachycardia and the secondary prevention of recurrent atrial fibrillation." | 4.90 | [Amiodarone and the thyroid]. ( Beckers, A; Benoit, A; Betea, D; Brescia, L; Delvenne, P; Hamoir, E, 2014) |
"An 88-year-old female, living independently in the community, developed duodenal and gastric ulcers from using overthe-counter naproxen sodium for pain related to a shoulder fracture and arthritis of the knees." | 4.88 | Gastrointestinal bleeding and possible hypothyroidism. ( Marshall, LL, 2012) |
" Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily controlled by L-thyroxine replacement, and does not require amiodarone withdrawal." | 4.88 | Amiodarone and the thyroid: a 2012 update. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Martino, E; Tomisti, L, 2012) |
"To summarize the mechanisms of iodine-induced hypothyroidism and hyperthyroidism, identify the risk factors for thyroid dysfunction following an iodine load, and summarize the major sources of excess iodine exposure." | 4.88 | Iodine-induced thyroid dysfunction. ( Braverman, LE; Leung, AM, 2012) |
"Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
"Amiodarone is a widely used antiarrythmic drug and can lead either to hypothyroidism or hyperthyroidism due to its molecular structure which is similar to levothyroxin." | 4.87 | [Amiodarone and thyroid]. ( Capraro, J; Thalmann, S, 2011) |
" Treatment with amiodarone may lead to changes in thyroid tests results and to development of hypothyroidism or thyrotoxicosis." | 4.82 | [Thyroid and cardiovascular disorders]. ( Gajek, J; Zyśko, D, 2004) |
"Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone." | 4.82 | [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]. ( Barta, K; Lorincz, I; Nagy, E; Simkó, J; Szabó, Z; Varga, E, 2004) |
"Amiodarone, a benzofuranic derivative, iodine-rich drug, has been used in pregnancy for either maternal or fetal tachyarrhythmias." | 4.81 | Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
"Pathogenesis, diagnostic procedures and therapy of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH) are briefly discussed." | 4.80 | [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism]. ( Gerber, H; Noth, D, 1999) |
"Amiodarone, an iodine-rich benzofuranic derivative, may often induce hyperthyroidism and hypothyroidism." | 4.79 | [Amiodarone-induced hypothyroidism followed by hyperthyroidism. Apropos of 2 new cases]. ( Kieffer, P; Saraceni, O; Wilhelm, JM, 1996) |
"Cases of hypothyroidism and hyperthyroidism associated with amiodarone therapy are described, and the mechanisms, clinical appearance, and management of amiodarone-induced thyroid dysfunction are discussed." | 4.78 | Amiodarone-induced thyroid dysfunction. ( Jaffe, CA; Khanderia, U; Theisen, V, 1993) |
" An increase of the thyroid iodine content (TIC) is observed in all patients at the exception of those who develop hypothyroidism under treatment." | 4.77 | [Thyroid function and amiodarone. Consequences on dysthyroidism testing]. ( Fragu, P; Schlumberger, M, 1985) |
"Amiodarone-associated hyperthyroidism had a different onset profile than hyperthyroidism associated with other drugs." | 3.96 | Time-to-onset analysis of amiodarone-associated thyroid dysfunction. ( Hosomi, K; Kinoshita, S; Takada, M; Yokoyama, S, 2020) |
" Amiodarone induced hypothyroidism is treated with levothyroxine and amiodarone taking is not interrupted." | 3.96 | Pharmacologically induced thyreopathy in patients with cardiovascular disease. ( Brutvan, T; Ježková, J; Krátký, J, 2020) |
" The study revealed hypothyroidism, iatrogenic due to the use of amiodarone." | 3.96 | An unexpected cause of residual renal function loss. ( Abrantes, C; Assunção, J; Furtado, T; Soares, E; Valério, P; Vaz, AG, 2020) |
" Here we describe a case of possible postoperative myxedema coma after subacute neck hematoma evacuation after hemithyroidectomy in a patient on concurrent amiodarone therapy." | 3.91 | Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report. ( Bouvet, M; Ho, G; Kelly, K; Meier, A; Tran, M; Vincent, L, 2019) |
"Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 3.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
"Amiodarone is used for the maintenance of sinus rhythm in patients with arrhythmias, but thyroid dysfunction (amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH)) is a common adverse effect." | 3.85 | The clinical value of regular thyroid function tests during amiodarone treatment. ( Benjamens, S; Dullaart, RPF; Links, TP; Rienstra, M; Sluiter, WJ; van Gelder, IC, 2017) |
" In patients with untreated amiodarone-induced hypothyroidism, but not in the other groups of patients, metformin reduced serum levels of thyrotropin and this effect correlated weakly with its action on insulin sensitivity." | 3.83 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. ( Gilowska, M; Krysiak, R; Okopień, B; Szkróbka, W, 2016) |
" Positive control was amiodarone and thyroxine, as a marker of amiodarone-induced hypothyroidism, a known adverse event with a clear temporal relationship to amiodarone initiation." | 3.81 | Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. ( Chan, EW; Choi, NK; Kao Yang, YH; Kimura, M; Kimura, T; Kubota, K; Lai, EC; Man, KK; Ooba, N; Park, BJ; Pratt, N; Roughead, EE; Sato, T; Shin, JY; Wong, IC, 2015) |
"Incidence and risk factors of amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH) were assessed." | 3.80 | Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study. ( Chang, JW; Chang, SL; Chen, PJ; Chen, SA; Huang, CJ; Huang, DF; Jap, TS; Lin, LY, 2014) |
"Although most patients remain clinically euthyroid, some develop amiodarone-induced hyperthyroidism (HPEAI) or hypothyroidism (HPOAI)." | 3.79 | [Thyroid dysfunction and amiodarone]. ( Carvalho, P; Costa, JM; Dias, P; Lima, J; Molina, MA; Rebelo, M; Vieira, JD, 2013) |
"Amiodarone is a di-iodated benzofuran derivative that is commonly used to treat patients with various cardiac arrhythmias." | 3.79 | [A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism]. ( Chae, HB; Cho, YS; Han, JH; Kang, KM; Kim, JS; Lim, JC; Park, SM, 2013) |
"Of the five cases reviewed (4 males, age range of 37 to 62 years), adult primary hypothyroidism was caused by amiodarone (1 case), chronic autoimmune thyroiditis (1 case), and by uncertain etiologies (3 cases)." | 3.79 | Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis. ( Cai, Y; Tang, L, 2013) |
"To define the prevalence and incidence of hypothyroidism in a group of CHF outpatients in stable clinical conditions, with particular reference to the role of amiodarone therapy." | 3.78 | Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone. ( Catanzaro, R; Ciccone, MM; Favale, S; Forleo, C; Giagulli, VA; Guastamacchia, E; Guida, P; Iacoviello, M; Licchelli, B; Monzani, F; Puzzovivo, A; Tafaro, E; Triggiani, V, 2012) |
" Laboratory studies revealed cardiogenic ascites coincided with nephrogenic ascites and subclinical amiodarone-induced hypothyroidism." | 3.78 | Development of refractory ascites during amiodarone therapy in a hemodialysis patient with nephrogenic and cardiogenic ascites. ( Chen, JD; Hwang, B; Lin, YF; Wang, JY, 2012) |
" Hypothyroidism, mainly found in countries without iodine deficiency, is substituted with levothyroxine and does not need amiodarone to be discontinued." | 3.78 | [Amiodarone and thyroid]. ( Maby-Mottet, V; Meyer, P; Ollo, D, 2012) |
"To report a case of postnatal, postoperative amiodarone-induced hypothyroidism in an infant with a congenital heart defect." | 3.77 | Severe amiodarone-induced hypothyroidism in an infant. ( Panagiotopoulos, C; Sanatani, S; Trudel, K, 2011) |
"Amiodarone protects patients with left ventricular systolic dysfunction (LVSD) against serious arrhythmias, but it also has numerous side effects on non-cardiac organs, such as the thyroid." | 3.77 | Thyroid hormone, amiodarone therapy, and prognosis in left ventricular systolic dysfunction. ( Carpeggiani, C; Coceani, M; Iervasi, G; L'abbate, A; Landi, P; Molinaro, S; Pingitore, A; Scalese, M, 2011) |
"We included 303 consecutive patients with amiodarone therapy for cardiac arrhythmias (260 with atrial fibrillation and 43 with ventricular arrhythmias)." | 3.77 | Determinants and outcome of amiodarone-associated thyroid dysfunction. ( Ahmed, S; Links, TP; Van Gelder, IC; Van Veldhuisen, DJ; Wiesfeld, AC, 2011) |
"Amiodarone-induced hypothyroidism (AIH) may occur in patients with or without underlying thyroid disorders." | 3.74 | Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Cosci, C; Dell'Unto, E; Gasperi, M; Lai, A; Martino, E; Sardella, C; Tanda, ML; Tomisti, L, 2008) |
"Amiodarone-induced thyrotoxicosis (AIT) with features consistent with both AIT type I (in which thyroid antibodies and nodular goiter are present) and AIT type II (which is not responsive to thionamide therapy and eventually leads to permanent hypothyroidism)." | 3.74 | Treatment of amiodarone-associated thyrotoxicosis. ( Franklyn, JA; Gammage, MD, 2007) |
"The long-term cardiac effects of amiodarone resemble many aspects of hypothyroidism." | 3.74 | Long-term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile. ( Futaki, S; Hayashi, Y; Kambe, F; Kodama, I; Lee, JK; Murata, Y; Seo, H; Shi, RQ; Takeuchi, Y, 2008) |
"Relationship between amiodarone-associated thyroid dysfunction and antiarrhythmic activity of amiodarone was studied in 27 patients (13 with hypothyroidism, 8 with hyperthyroidism, 6 with euthyroid hyperthyroxinemia)." | 3.73 | [Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function]. ( Bakalov, SA; Golitsyn, SP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sitina, VK; Sviridenko, NIu, 2005) |
"Blood lipid levels were measured in 23 patients with amiodarone associated hypothyroidism (most of them had ischemic heart disease)." | 3.73 | [Lipid blood spectrum in patients with amiodarone associated hypothyroidism. Effect of replacement therapy with L-thyroxine]. ( Bakalov, SA; Golitsyn, SP; Kotkina, TI; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
" Most respondents lived in iodine-sufficient areas and observed that amiodarone-induced hypothyroidism (AIH) is more common than AIT." | 3.73 | Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. ( Albino, CC; Bartalena, L; Diehl, LA; Graf, H; Martino, E; Romaldini, JH; Wiersinga, WM, 2006) |
"Eleven patients developed amiodarone- induced thyrotoxicosis (AIT), ten developed amiodarone-induced hypothyroidism (AIH) and one patient first developed AIT, followed by AIH." | 3.72 | Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction. ( Acu, B; Alyan, O; Arda, K; Demirkan, D; Ozdemir, O; Soylu, M, 2003) |
" Overall and subgroup analyses were performed based on patient characteristics such as presence of thyroid-stimulating hormone (TSH) level, interval since last heart failure clinic appointment, presence of thyroid replacement therapy, amiodarone use, NYHA functional class, and attending physician." | 3.72 | Assessment of hypothyroidism in patients with chronic heart failure. ( Middleton, SC; Spencer, AP, 2004) |
"Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | 3.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
"During 1 year of amiodarone intake development of amiodarone-associated thyroid dysfunction was observed in 25% of patients (hypothyroidism and thyrotoxicosis in 19." | 3.72 | [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction]. ( Bakalov, SA; Golitsin, SP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Soboleva, VA; Sviridenko, NIu, 2004) |
"In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 3.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
"Primary hypothyroidism may occur as a consequence of, or concomitant, with numerous therapies such as amiodarone, lithium, cytokines, antithyroid drugs, iodine, etc." | 3.70 | [Hypothyroidism induced by drugs, radiotherapy, and surgery]. ( Caron, P, 1998) |
"Amiodarone may induce hyper- or hypothyroidism." | 3.70 | High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment. ( Balestrieri, A; Lai, ME; Loviselli, A; Mandas, A; Mariotti, S; Martino, E; Murenu, S; Sau, F; Vacquer, S; Valentino, L, 1999) |
"Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 3.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
"A comparative study on ventricular electrophysiologic effects of experimental hypothyroidism and chronic oral amiodarone administration was made in canine models, with the application of electrical stimulation and monophasic action potential recording." | 3.69 | Comparison of cardiac electrophysiologic effects of experimental hypothyroidism and chronic oral amiodarone administration in dogs. ( Li, JM; Liu, PM; Tang, Y; Wu, W; Zhang, XM, 1994) |
"We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 3.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
"Studies have suggested that chronic amiodarone treatment (a class III antiarrhythmic) may have effects on the myocardium that resemble those of hypothyroidism." | 3.69 | Amiodarone decreases Na,K-ATPase alpha 2 and beta 2 expression specifically in cardiac ventricle. ( Bersohn, MM; Hensley, CB; McDonough, AA; Sarma, JS; Singh, BN, 1994) |
"Amiodarone, an iodine-rich cardiac drug, may induce thyrotoxicosis (AIT), which can occur in patients with preexisting thyroid abnormalities and in subjects with apparently normal thyroid glands." | 3.69 | Serum interleukin-6 in amiodarone-induced thyrotoxicosis. ( Aghini-Lombardi, F; Bartalena, L; Braverman, LE; Brogioni, S; Grasso, L; Martino, E, 1994) |
"Parameters that are assumed to be under direct control by thyroid hormonal state were evaluated in amiodarone-treated, hypo- and hyperthyroid rats." | 3.69 | Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats. ( Gøtzsche, LB; Orskov, H, 1994) |
"Optimal daily levothyroxine (LT4) dosage is reported to be significantly smaller in the elderly with primary hypothyroidism when compared with their younger counterparts." | 3.69 | Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology. ( Kabadi, UM, 1997) |
"Hypothyroidism followed by hyperthyroidism is described in two patients treated by amiodarone." | 3.68 | [Hypothyroidism followed by hyperthyroidism under treatment with amiodarone]. ( Burger, A; Goumaz, MO; Martin-Du Pan, RC; Perrotet, C, 1993) |
"Plasma iodine was below 40 micrograms/l in 57 (7%) patients, most of whom had hypothyroidism; 40-80 micrograms/l in 439 (55%) patients, most of whom had normal thyroid hormone function; 80-250 micrograms/l in 240 (30%) patients, most of whom had hyperthyroidism; and above 250 micrograms/l in 63 (8%) patients, almost all of whom had iodine overload caused by iodinated drugs, particularly amiodarone, resulting in euthyroidism (24%), hyperthyroidism (36%), and hypothyroidism (16%)." | 3.68 | Use of plasma iodine assay for diagnosing thyroid disorders. ( Allain, P; Barbot, N; Berre, S; Bigorgne, JC; Krari, N; Lainé-Cessac, P; Le Bouil, A; Rohmer, V, 1993) |
" The potent antithyroid drug, potassium perchlorate (KClO4), is used successfully to treat amiodarone-induced thyrotoxicosis, but it is less well known as potential treatment in amiodarone-induced hypothyroidism." | 3.68 | Treatment of amiodarone-induced hypothyroidism with potassium perchlorate. ( Nikkels, RE; Prummel, MF; van Dam, EW; Wiersinga, WM, 1993) |
"In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule." | 3.68 | Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. ( Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M, 1992) |
"Amiodarone-induced thyrotoxicosis (AIT) occurs most frequently in patients with underlying thyroid disease and is generally believed to be due to the iodine contamination of amiodarone and iodine released by the metabolism of the drug." | 3.68 | Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. ( Bianconi, L; Braverman, LE; Gardini, E; Gavaruzzi, G; Minelli, R; Neri, TM; Roti, E; Ugolotti, G, 1992) |
"Five cases are studied in which amiodarone (AM) was given during pregnancy, in two of them also during the breast feeding period, to estimate the risks for adverse effects." | 3.68 | Use of amiodarone during pregnancy. ( de Vijlder, JJ; Plomp, TA; Vulsma, T, 1992) |
"To determine the incidence and predictability and to elucidate the pathogenesis of amiodarone-induced thyrotoxicosis (AIT) and hypothyroidism (AIH)." | 3.68 | Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. ( Plomp, TA; Trip, MD; Wiersinga, W, 1991) |
"Clinical and chemical variables of thyroid function were studied in 26 patients with symptomatic ventricular tachyarrhythmias before and during long-term oral treatment with amiodarone." | 3.67 | Clinical and chemical assessment of thyroid function during therapy with amiodarone. ( Alpert, B; Amico, JA; Klein, I; Richardson, V, 1984) |
"Amiodarone induced hypothyroidism (AIH) is assumed to result from a failure of the thyroid to escape from the inhibitory effect of inorganic iodine on its organification as a consequence of uninhibited iodide trapping." | 3.67 | 24 h-kinetics of iodide uptake in amiodarone induced hypothyroidism. ( Dumont, JE; Sarot, J; Soupart, A; Surmont, DW; Unger, J, 1989) |
"We report a case of a patient with hypothyroidism due to amiodarone." | 3.67 | [Transitory efficacy of potassium perchlorate in hypothyroidism caused by amiodarone]. ( Confalonieri, F; Foresti, V; Parisio, E; Scolari, N; Terenzio, C; Villa, A, 1989) |
" We have distinguished four groups of patients: group A (n = 8): patients with true hyperthyroidism induced by drug administration; group B (n = 11): patients with mild hyperthyroid symptoms, but isolated thyroxine increase or dissociation between different indexes of thyroid function; group C (n = 5): patients with normal thyroid hormone levels, but increased TSH levels; group D (n = 6): patients who appeared really clinically euthyroid, with normal thyroid hormone levels and normal TSH response to TRH." | 3.67 | Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination. ( Barbarino, A; Calabrò, F; De Marinis, L; Lippa, S; Littarru, GP; Mancini, A; Oradei, A; Sandric, S; Sciuto, R, 1989) |
"We studied the effect of potassium perchlorate (KClO4) in patients with hypothyroidism due to amiodarone." | 3.67 | Short term administration of potassium perchlorate restores euthyroidism in amiodarone iodine-induced hypothyroidism. ( Aghini-Lombardi, F; Baschieri, L; Braverman, L; Lenziardi, M; Mariotti, S; Martino, E; Morabito, S; Pinchera, A; Safran, M, 1986) |
"We have determined the effects of chronic amiodarone treatment on lipid metabolism and compared them with those of hypothyroidism in the rat." | 3.67 | Effect of amiodarone on serum lipids, lipoprotein lipase, and hepatic triglyceride lipase. ( Bagchi, N; Brown, TR; Kasim, SE; Khilnani, S, 1987) |
"We compared results of five sensitive immunometric assays of serum thyrotropin (TSH) in controls and in different groups of patients with hyperthyroidism, untreated or treated; secondary hypothyroidism; nonthyroidal illness (NTI); or depression; or who were being treated with amiodarone." | 3.67 | Clinical significance of a low concentration of thyrotropin: five immunometric "kit" assays compared. ( Askienazy, S; Milhaud, G; Piketty, ML; Talbot, JN, 1987) |
"A 54-year-old man on regular haemodialysis developed severe amiodarone-induced hypothyroidism after an unusually short latency period." | 3.67 | Severe hypothyroidism induced by amiodarone in a dialysis patient. ( Catalano, C; Costante, G; Enia, G; Maggiore, Q; Zoccali, C, 1987) |
"Amiodarone, an iodine-rich drug widely used for the treatment of cardiac tachyarrhythmias, may induce either hyperthyroidism or hypothyroidism." | 3.67 | Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. ( Aghini-Lombardi, F; Bambini, G; Bartalena, L; Braverman, LE; Ceccarelli, C; Lenziardi, M; Mariotti, S; Martino, E; Pinchera, A; Safran, M, 1987) |
" There were no differences in age, sex, dose of amiodarone, type or severity of underlying heart disease or baseline serum thyroxine levels in patients who developed hypothyroidism (n = 32) or hyperthyroidism (n = 5) or remained euthyroid (n = 62)." | 3.67 | Thyroid dysfunction during chronic amiodarone therapy. ( Albert, SG; Alves, LE; Rose, EP, 1987) |
"Both hyperthyroidism and hypothyroidism have been noted to occur in some patients treated with amiodarone for cardiac arrhythmias." | 3.67 | Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function. ( Borowski, GD; Garofano, CD; Greenspan, AM; Horowitz, LN; Rose, LI; Rotmensch, HR; Spielman, SR, 1985) |
"Amiodarone, an iodinated benzofuran derivative, has electrophysiologic effects on cardiac muscle akin to those of hypothyroidism." | 3.66 | Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. ( Nademanee, K; Singh, BN, 1983) |
" Both, hypo- and hyperthyroidism can occur, probably as a result of the iodine overload on a preexisting thyroid disorder." | 3.66 | Amiodarone and the thyroid gland. A review. ( Jonckheer, MH, 1981) |
"Amiodarone is a common anti-arrhythmic agent mostly used to treat and prevent different kinds of arrhythmia with several considerable side effects, most commonly on the thyroid gland." | 3.01 | Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis. ( Bondariyan, N; Heidarpour, M; Mohammadi, K; Rezvanian, H; Shafie, D; Vakhshoori, M, 2023) |
"Amiodarone may cause amiodarone-induced hypothyroidism (AIH) or amiodarone-induced thyrotoxicosis (AIT)." | 2.82 | AMIODARONE AND THYROID DYSFUNCTION. ( Alfirević, M; Bakula, M; Marić, N; Medić, F; Mucić, K, 2022) |
" During the follow-up period a transient rise in T4 and T3 concentrations was observed in two patients in Group I when the methimazole dosage was tapered or stopped because of agranulocytosis." | 2.66 | Effect of amiodarone on serum T4 and T3 levels in hyperthyroid patients treated with methimazole. ( Decoster, C; Unger, J; Van Reeth, O, 1987) |
"Hyperthyroidism, is less frequent in this clinical context but it necessitates of immediate treatment because of its negative effects on cardiovascular balance." | 2.58 | Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches. ( Gioia, MI; Iacoviello, M; Parisi, G; Rizzo, C; Triggiani, V, 2018) |
"Amiodarone is an antiarrhythmic drug frequently used in everyday clinical practice." | 2.53 | [Clinical procedure in amiodarone-induced thyroid dysfunction]. ( Cygankiewicz, I; Kosmalski, M; Michalak, R; Ptaszyński, P; Różycka-Kosmalska, M; Wranicz, JK; Zieleniewski, W, 2016) |
"Amiodarone is an effective medication for the treatment of cardiac arrhythmias." | 2.52 | Amiodarone-induced thyroid dysfunction. ( Danzi, S; Klein, I, 2015) |
"Amiodarone can cause both hypothyroidism (AIH, amiodarone-induced hypothyroidism) and thyrotoxicosis (AIT, amiodarone-induced thyrotoxicosis)." | 2.52 | Amiodarone and the thyroid. ( Bartalena, L; Bednarczuk, T; Hubalewska-Dydejczyk, A; Jabrocka-Hybel, A; Kamiński, G; Kostecka-Matyja, M; Pach, D; Ruchała, M, 2015) |
" Of all the antiarrhythmic drugs hitherto used, AM has the most adverse effects on the thyroid gland." | 2.48 | [Effect of amiodarone on the thyroid function and safety of the therapy--what's new]. ( Czarnywojtek, A; Florek, E; Hen, K; Ruchała, M; Stangierski, A; Warmuz-Stangierska, I; Zdanowska, J, 2012) |
"Amiodarone is a structural analogue of thyroid hormone, and some of its anti-arrhythmic actions and toxicity are attributable to its interaction with nuclear receptors of thyroid hormones." | 2.48 | [Amiodarone and thyroid dysfunction]. ( Bruno, OD; Rizzo, LF, 2012) |
"Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of macrovesicular steatosis, cellular ballooning, and inflammation." | 2.48 | A myriad of pathways to NASH. ( Larrain, S; Rinella, ME, 2012) |
"Amiodarone is a benzofuran derivative approved for the treatment of cardiac arrhythmias." | 2.46 | Effects of amiodarone therapy on thyroid function. ( Cohen-Lehman, J; Dahl, P; Danzi, S; Klein, I, 2010) |
"Amiodarone treatment affects thyroid status in about the half of patients." | 2.46 | [Amiodarone-induced thyroid gland dysfunctions]. ( Caglayan, E; Dietlein, M; Er, F; Erdmann, E; Gassanov, N, 2010) |
"Amiodarone is a potent antiarrhythmic drug associated with thyroid dysfunction." | 2.46 | Amiodarone and thyroid dysfunction. ( Padmanabhan, H, 2010) |
"Amiodarone has been used widely for treating resistant tachyarrhythmias in the past three decades." | 2.45 | Benzofuran derivatives and the thyroid. ( Han, TS; Vanderpump, MP; Williams, GR, 2009) |
"Amiodarone is a frequently used antiarrhythmic drug with a high antiarrhythmic potency." | 2.44 | [Thyroid and treatment with amiodarone diagnosis, therapy and clinical management]. ( Mikosch, P, 2008) |
"Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties." | 2.43 | Amiodarone and the thyroid. ( Basaria, S; Cooper, DS, 2005) |
"Hypothyroidism has an inverse hemodynamic effect and is less noisy, usually limited to relative bradycardia." | 2.43 | [Cardiac consequences of clinical dysthyroidism. Pathophysiological, clinical, and epidemiologic data]. ( Brafin-Busch, MS; Goichot, B; Schlienger, JL; Vinzio, S, 2005) |
"Amiodarone is an antiarhytmic drug used in many clinical situations for its probed effect; it is also preferred in particular groups of patients (heart failure, post-ischemical) for its safe and its prognostic benefits." | 2.42 | [Amiodarone and thyroid dysfunction: a pending problem]. ( Perazza, L; Scardi, S, 2003) |
"Amiodarone is an iodine-rich drug." | 2.42 | [Amiodarone and the thyroid gland]. ( Bednarek-Tupikowska, G; Bugajski, J; Filus, A; Kuliczkowska, J, 2004) |
"Amiodarone is an iodine-rich drug used to treat cardiac dysrhythmias." | 2.42 | Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. ( Backeljauw, PF; Jackson, WA; Lomenick, JP, 2004) |
"Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease." | 2.41 | The effects of amiodarone on the thyroid. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
"Iodine is an essential element for thyroid hormone synthesis." | 2.41 | Iodine-Induced hypothyroidism. ( Georgopoulos, N; Kyriazopoulou, V; Markou, K; Vagenakis, AG, 2001) |
" After approximately 30 days, the perchlorate dosage can be tapered or stopped, continuing with thionamides alone." | 2.40 | Perchlorate and the thyroid gland. ( Wolff, J, 1998) |
"Amiodarone has been used in cardiology for more than 20 years as an anti-angina and anti-arrhythmia agent." | 2.39 | [Effects of amiodarone on thyroid function]. ( Caron, P, 1995) |
" A dose-response relationship was observed between the 1-year accumulated amiodarone dose and the subsequent 5-year cumulative incidence of thyroid dysfunction." | 1.91 | Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. ( Ali, SA; Butt, JH; Ersbøll, M; Fosbøl, E; Gustafsson, F; Jøns, C; Kristensen, SL; Køber, L; Mogensen, UM; Rørth, R; Selmer, C; Vinding, NE; Weeke, PE; Westergaard, LM, 2023) |
"Ventricular tachycardia was detected by electrocardiography." | 1.72 | Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report. ( Cheng, YC; Lee, IT; Liao, PH; Liu, PY, 2022) |
"BACKGROUND Myxedema coma is an uncommon severe thyroid disorder that is fatal in 25-60% of cases." | 1.56 | Amiodarone-Associated Myxedema Coma. ( Donato, A; Hirani, F; Jayatilaka, S; Zagorski, E, 2020) |
"Myxedema coma is a rare complication of hypothyroidism." | 1.51 | Myxedema coma: four patients diagnosed at the Internal Medicine Department of the Dr. Negrin University Hospital in Spain. ( Kechida, M; Ortega, SS; Ortiz, MBA; Saint-Mezard, V; Villalba, NL; Zamorano, NF; Zulfiqar, AA, 2019) |
"Amiodarone induced thyrotoxicosis is a complex condition marked by two different pathophysiological mechanisms with different treatments." | 1.43 | [Iodine excess induced thyroid dysfunction]. ( Egloff, M; Philippe, J, 2016) |
" However, the use of RAI in euthyroid patients requiring chronic administration of amiodarone (AM) where other antiarrhythmic drugs may lack efficacy is still controversial." | 1.40 | Results of preventive radioiodine therapy in euthyroid patients with history of hyperthyroidism prior to administration of amiodarone with permanent atrial fibrillation--a preliminary study. ( Czarnywojtek, A; Czepczyński, R; Królicki, L; Kwiecińska, B; Miechowicz, I; Płazińska, MT; Ruchała, M; Woliński, K; Zgorzalewicz-Stachowiak, M, 2014) |
"She presented generalized skin rash, arthralgia on upper and lower extremities, associated with difficulty to walk." | 1.39 | An unexpected side-effect of a commonly used drug. ( Adorno, E; Fernández González, F; Fernández González, R; Miranda, S; Nieves, J; Santiago Casiano, M, 2013) |
"Here, we report a patient with chronic renal failure who developed EPO-resistant anemia after amiodarone treatment for arrhythmia." | 1.35 | Amiodarone-induced hypothyroidism with EPO-resistant anemia in a patient with chronic renal failure. ( Chang, PM; Ng, YY, 2008) |
" Compared with patients without AITD, there was no difference regarding dosage or duration of therapy, heart rhythm disorder or baseline cardiac condition." | 1.35 | How frequently should a patient taking amiodarone be screened for thyroid dysfunction? ( Campos, D; de Jesus, AM; Maciel, BC; Maciel, LM; Magalhães, PK; Melato, LH; Pazin-Filho, A, 2009) |
"Transient hypothyroidism was observed in only two patients (5%) with AIH, though was not observed in TMNG." | 1.35 | Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT). ( Bartkowiak, Z; Czarnywojtek, A; Czepczynski, R; Florek, E; Ruchala, M; Sowinski, J; Szczepanek, E; Wasko, R; Zamyslowska, H; Zgorzalewicz-Stachowiak, M, 2009) |
"Dronedarone was given in Wistar rats (90 mg/kg, once daily (od) for 2 weeks) (DRON), while untreated animals served as controls (CONT)." | 1.33 | Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. ( Cokkinos, DV; Malliopoulou, V; Moraitis, P; Mourouzis, I; Paizis, I; Pantos, C; Sfakianoudis, K; Tzeis, S; Varonos, DD, 2005) |
"To analyze occurrence of thyroid dysfunction due to regular long-term intake of amiodaron (for one year), to search for predictors of amiodaron-induced hypothyroidism and thyrotoxicosis." | 1.33 | [Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron]. ( Bakalov, SA; Golitsyn, SP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
"Amiodarone, used in the treatment of cardiac arrhythmias, is associated with thyroid dysfunction." | 1.33 | Amiodarone-induced thyroid dysfunction in a tertiary center in south Brazil. ( Bruch, RS; Brum, G; Cunha, CP; Francisconi, A; Gus, M; Schaan, BD; Zottis, B, 2005) |
"Amiodarone is a widely used anti-arrythmic drug with considerable potential to cause thyroid dysfunction because of its 35% iodine content." | 1.33 | [The effects of amiodaron on the thyroid function]. ( Kucharczyk, A; Kucharczyk, P; Michałkiewicz, D, 2006) |
"Hyperthyroidism is more common than hypothyroidism and may be explained by increased iodine intake." | 1.31 | [Incidence and timing of thyroid dysfunction with long-term amiodarone therapy]. ( Baudusseau, O; Dupuis, JM; Geslin, P; Rouleau, F; Victor, J, 2001) |
"Amiodarone (AMD) is an antiarrhythmic drug which contains 37% of iodine." | 1.30 | Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases. ( Berardi, R; Cioni, M; Grosso, S; Morgese, G, 1998) |
"Amiodarone is a widely used antiarrhythmic drug, the mechanisms of action of which remain incompletely understood." | 1.30 | Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes. ( Bosch, RF; Gaspo, R; Li, GR; Nattel, S, 1999) |
"Amiodarone (AMD) is a powerful anti-arrhythmic drug used for the treatment of a wide variety of cardiac arrhythmias and its most striking feature is its high iodine content." | 1.30 | Amiodarone compared with iodine exhibits a potent and persistent inhibitory effect on TSH-stimulated cAMP production in vitro: a possible mechanism to explain amiodarone-induced hypothyroidism. ( Boyages, SC; Pitsiavas, V; Smerdely, P, 1999) |
"It is stated that CHD patients with arrhythmia develop latent hypothyrosis of T3-low-syndrome type." | 1.29 | [The effect of kordaron on thyroid function in patients with ischemic heart disease]. ( Tereshchenko, IV; Tsepelev, VV, 1995) |
"Amiodarone is an iodine-rich drug used in the treatment of resistant cardiac arrhythmias." | 1.29 | Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
"Amiodarone is a benzofurane derivative which contains an appreciable amount of iodine (37%)." | 1.28 | [Effects of amiodarone on the thyroid gland in euthyroid and hypothyroid animals]. ( Cvejić, D; Mićić, JV; Savin, S; Sinadinović, J, 1992) |
"Hypothyroidism was diagnosed in 11 (in 8 by the finding of elevated TSH)." | 1.28 | [Complications of low-dose amiodarone]. ( Feigl, D; Gilad, R; Katz, E, 1991) |
"Amiodarone is a diiodinated benzofuran derivative that has some structural similarities to the thyroid hormones and contains two iodine atoms per molecule." | 1.28 | Amiodarone antagonizes the effects of T3 at the receptor level: an additional mechanism for its in vivo hypothyroid-like effects. ( Lambert, C; Paradis, P; Rouleau, J, 1991) |
"Treatment with amiodarone was continued; however, therapy with L-thyroxin was initiated, followed by a complete regression of the goiter." | 1.28 | Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis. ( Ish-Shalom, S; Kaplan, J, 1991) |
"Amiodarone dose was 2,390 +/- 65 mg/week, and follow-up 20 +/- 9 months (minimum 9 months)." | 1.28 | [Thyroid clinical dysfunction in patients chronically treated with amiodarone]. ( Alvarez Gándara, D; Batista, J; García, RV; Gómez Sobreira, M; Lázaro Enguis, J; Moreiras, M, 1990) |
"Amiodarone treatment alters both the levels of serum lipids and thyroid hormones." | 1.28 | Amiodarone-induced changes in lipid metabolism. ( Bagchi, N; Brown, TR; Jackson, K; Kasim, SE; Khilnani, S; Lehmann, MH; Steinman, RT, 1990) |
"Hypothyroidism was induced with intraperitoneal (i." | 1.28 | Attenuation of class 3 and sinus node effects of amiodarone by experimental hypothyroidism. ( Davies, M; McCans, J; Nattel, S; Talajic, M, 1989) |
"Hypothyroidism was diagnosed in 11 patients (12%), and a further 11 had tests consistent with a "failing thyroid." | 1.27 | Effect of amiodarone on thyroid hormone economy. ( Glick, S; Posner, J; Sobel, RJ, 1984) |
"Hyperthyroidism was a more frequent (9." | 1.27 | Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. ( Aghini-Lombardi, F; Aronin, N; Fay, M; Haffajee, C; Lenziardi, M; Macchia, E; Martino, E; Pacchiarotti, A; Rajatanavin, R; Safran, M, 1984) |
"In Amiodarone-treated euthyroid patients, mean T4, fT4 and rT3 values were significantly (p less than 0,01) higher than those of control subjects; TSH levels were normal in all the groups studied." | 1.27 | [Thyroid function in patients chronically treated with amiodarone]. ( Bassi, F; Borghi, A; Brocchi, A; Cappelli, G; Fazzini, PF; Gheri, RG; Marchi, F; Paladini, S; Pratesi, E; Pucci, P, 1983) |
"Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance." | 1.27 | Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases. ( Atkinson, AB; Campbell, NP; Ferguson, WR; Geddes, JS; Hawthorne, GC; Postlethwaite, W; Sheridan, B, 1985) |
"Amiodarone treatment induced a significant increase in serum total and free T3 (from 2." | 1.27 | Decreased TSH response to TRH induced by amiodarone. ( Beckers, C; Burger, AG; De Nayer, P; Lambert, M, 1988) |
"Amiodarone is a powerful anti-arrhythmic drug." | 1.27 | Noncardiac side-effects of long-term oral amiodarone in the elderly. ( Bailey, RJ; Hyatt, RH; Martin, A; Sinha, B; Vallon, A, 1988) |
"Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 1.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
" Accompanying the decreases in CL were increases in the terminal disposition half-life (T1/2 gamma), 89% (18-34 hr) with the 45-mg/kg dose and 185% (20-57 hr) after the 80-mg/kg dose." | 1.27 | Amiodarone pharmacokinetics. III. Influence of thyroid dysfunction on amiodarone absorption and disposition. ( Ueda, CT; Weir, SJ, 1988) |
"An unusual case of recurrence of amiodarone pulmonary toxicity is described." | 1.27 | [Recurrent alveolitis caused by amiodarone]. ( Ciani, F; Padrini, R; Pandullo, C; Pivotti, F; Scardi, S, 1986) |
" Electrophysiologic data obtained before and during thyroxine replacement therapy showed that hypothyroidism lengthens the effective refractory period of the atria, AV node, bypass tract and His-Purkinje system (that in the ventricle not being measured); this lengthening resembles the effects of long-term administration of amiodarone." | 1.27 | Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block. ( Brun, S; Gaita, F; Mangiardi, L; Nademanee, K; Presbitero, P; Singh, BN, 1986) |
"A physiological dose of iodine is necessary for thyroid hormonogenesis, but in pharmacological dosage it is a danger." | 1.26 | [Iatrogenic thyroid pathology]. ( Léger, AF; Savoie, JC, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 79 (27.53) | 18.7374 |
1990's | 65 (22.65) | 18.2507 |
2000's | 65 (22.65) | 29.6817 |
2010's | 63 (21.95) | 24.3611 |
2020's | 15 (5.23) | 2.80 |
Authors | Studies |
---|---|
Yokoyama, S | 2 |
Tanaka, Y | 1 |
Hosomi, K | 5 |
Takada, M | 5 |
Mohammadi, K | 1 |
Shafie, D | 1 |
Vakhshoori, M | 1 |
Bondariyan, N | 1 |
Rezvanian, H | 1 |
Heidarpour, M | 1 |
Bogazzi, F | 8 |
Cappellani, D | 1 |
Liao, PH | 1 |
Cheng, YC | 1 |
Liu, PY | 1 |
Lee, IT | 1 |
Rahimi-Bashar, F | 1 |
Vahedian-Azimi, A | 1 |
Dalvand, S | 1 |
Karimi, L | 1 |
Moshkani, M | 1 |
Alimohamadi, Y | 1 |
Johnston, TP | 1 |
Sahebkar, A | 1 |
Ali, SA | 2 |
Ersbøll, M | 2 |
Vinding, NE | 2 |
Butt, JH | 2 |
Rørth, R | 2 |
Selmer, C | 2 |
Westergaard, LM | 2 |
Mogensen, UM | 2 |
Weeke, PE | 2 |
Jøns, C | 2 |
Gustafsson, F | 2 |
Fosbøl, E | 2 |
Køber, L | 2 |
Kristensen, SL | 2 |
Medić, F | 1 |
Bakula, M | 2 |
Alfirević, M | 1 |
Mucić, K | 1 |
Marić, N | 1 |
Kinoshita, S | 1 |
Villalba, NL | 1 |
Zulfiqar, AA | 1 |
Saint-Mezard, V | 1 |
Ortiz, MBA | 1 |
Kechida, M | 1 |
Zamorano, NF | 1 |
Ortega, SS | 1 |
Brutvan, T | 1 |
Krátký, J | 1 |
Ježková, J | 1 |
Soares, E | 1 |
Valério, P | 1 |
Abrantes, C | 1 |
Furtado, T | 1 |
Assunção, J | 1 |
Vaz, AG | 1 |
Schubert, L | 1 |
Bricaire, L | 1 |
Groussin, L | 1 |
Eilsberger, F | 1 |
Luster, M | 1 |
Feldkamp, J | 1 |
Zagorski, E | 1 |
Jayatilaka, S | 1 |
Hirani, F | 1 |
Donato, A | 1 |
Christidis, G | 1 |
Lammert, F | 1 |
Krawczyk, M | 1 |
Tomisti, L | 3 |
Di Bello, V | 1 |
Martino, E | 16 |
Benjamens, S | 1 |
Dullaart, RPF | 1 |
Sluiter, WJ | 1 |
Rienstra, M | 1 |
van Gelder, IC | 2 |
Links, TP | 2 |
Yamato, M | 3 |
Wada, K | 3 |
Fujimoto, M | 3 |
Hayashi, T | 3 |
Oita, A | 3 |
Rowland, A | 2 |
Sorich, MJ | 1 |
Mangoni, AA | 1 |
García-García, E | 1 |
De Ceballos, RD | 1 |
Irimie, A | 1 |
Piciu, D | 1 |
Rizzo, C | 1 |
Gioia, MI | 1 |
Parisi, G | 1 |
Triggiani, V | 2 |
Iacoviello, M | 2 |
Binz-Siegmann, K | 1 |
Tran, M | 1 |
Vincent, L | 1 |
Ho, G | 1 |
Kelly, K | 1 |
Bouvet, M | 1 |
Meier, A | 1 |
Creo, A | 1 |
Anderson, H | 1 |
Cannon, B | 1 |
Lteif, A | 1 |
Kumar, S | 1 |
Tebben, P | 1 |
Iqbal, AM | 1 |
Ramakrishna, A | 1 |
Pittock, S | 1 |
Huang, V | 1 |
Wolf, RM | 1 |
El-Eshmawy, MM | 1 |
Shahin, M | 1 |
Furtak, A | 1 |
Wędrychowicz, A | 1 |
Kalicka-Kasperczyk, A | 1 |
Januś, D | 1 |
Wójcik, M | 1 |
Kordon, Z | 1 |
Rudziński, A | 1 |
Starzyk, JB | 1 |
Hen, K | 1 |
Czarnywojtek, A | 3 |
Stangierski, A | 1 |
Warmuz-Stangierska, I | 1 |
Zdanowska, J | 1 |
Florek, E | 2 |
Ruchała, M | 3 |
Lima, J | 1 |
Carvalho, P | 1 |
Molina, MA | 1 |
Rebelo, M | 1 |
Dias, P | 1 |
Vieira, JD | 1 |
Costa, JM | 1 |
Cho, YS | 1 |
Han, JH | 1 |
Chae, HB | 1 |
Kim, JS | 1 |
Kang, KM | 1 |
Park, SM | 1 |
Lim, JC | 1 |
Danzi, S | 3 |
Klein, I | 5 |
Fernández González, F | 1 |
Miranda, S | 1 |
Santiago Casiano, M | 1 |
Nieves, J | 1 |
Adorno, E | 1 |
Fernández González, R | 1 |
Lakatos, G | 1 |
Nádházi, Z | 1 |
Igaz, P | 1 |
Rácz, K | 1 |
Huang, CJ | 1 |
Chen, PJ | 1 |
Chang, JW | 1 |
Huang, DF | 1 |
Chang, SL | 1 |
Chen, SA | 2 |
Jap, TS | 1 |
Lin, LY | 1 |
Zgorzalewicz-Stachowiak, M | 2 |
Woliński, K | 1 |
Płazińska, MT | 1 |
Miechowicz, I | 1 |
Kwiecińska, B | 1 |
Czepczyński, R | 2 |
Królicki, L | 1 |
Olsen, JS | 1 |
Carlé, A | 1 |
Thomsen, HH | 1 |
Hudzik, B | 1 |
Zubelewicz-Szkodzinska, B | 1 |
Capone, CA | 1 |
Gebb, J | 1 |
Dar, P | 1 |
Shenoy, RU | 1 |
Brescia, L | 1 |
Benoit, A | 1 |
Betea, D | 1 |
Delvenne, P | 1 |
Hamoir, E | 1 |
Beckers, A | 1 |
Pratt, N | 1 |
Chan, EW | 1 |
Choi, NK | 1 |
Kimura, M | 1 |
Kimura, T | 1 |
Kubota, K | 1 |
Lai, EC | 1 |
Man, KK | 1 |
Ooba, N | 1 |
Park, BJ | 1 |
Sato, T | 1 |
Shin, JY | 1 |
Wong, IC | 1 |
Kao Yang, YH | 1 |
Roughead, EE | 1 |
Jabrocka-Hybel, A | 1 |
Bednarczuk, T | 1 |
Bartalena, L | 12 |
Pach, D | 1 |
Kamiński, G | 1 |
Kostecka-Matyja, M | 1 |
Hubalewska-Dydejczyk, A | 1 |
Takeuchi, D | 1 |
Honda, K | 1 |
Shinohara, T | 1 |
Inai, K | 1 |
Toyohara, K | 1 |
Nakanishi, T | 1 |
Huang, JH | 2 |
Lin, YK | 2 |
Hsieh, MH | 2 |
Chiu, WC | 1 |
Chen, YJ | 2 |
Różycka-Kosmalska, M | 1 |
Michalak, R | 1 |
Kosmalski, M | 1 |
Ptaszyński, P | 1 |
Wranicz, JK | 1 |
Zieleniewski, W | 1 |
Cygankiewicz, I | 1 |
Krysiak, R | 1 |
Gilowska, M | 1 |
Szkróbka, W | 1 |
Okopień, B | 1 |
Somberg, J | 1 |
Molnar, J | 1 |
Egloff, M | 1 |
Philippe, J | 1 |
Koukkou, EG | 1 |
Roupas, ND | 1 |
Markou, KB | 1 |
Dell'Unto, E | 1 |
Cosci, C | 1 |
Sardella, C | 1 |
Tanda, ML | 2 |
Lai, A | 1 |
Gasperi, M | 2 |
Aghini-Lombardi, F | 10 |
Han, TS | 1 |
Williams, GR | 1 |
Vanderpump, MP | 1 |
Hofmann, A | 1 |
Nawara, C | 1 |
Ofluoglu, S | 1 |
Holzmannhofer, J | 1 |
Strohmer, B | 1 |
Pirich, C | 1 |
Chang, PM | 1 |
Ng, YY | 1 |
Wiersinga, WM | 9 |
Luciani, R | 1 |
Falcone, C | 1 |
Principe, F | 1 |
Punzo, G | 1 |
Menè, P | 1 |
Pazin-Filho, A | 1 |
de Jesus, AM | 1 |
Magalhães, PK | 1 |
Melato, LH | 1 |
Campos, D | 1 |
Maciel, BC | 1 |
Maciel, LM | 1 |
Ruchala, M | 1 |
Wasko, R | 1 |
Szczepanek, E | 1 |
Zamyslowska, H | 1 |
Bartkowiak, Z | 1 |
Sowinski, J | 1 |
Mahitchi, E | 1 |
Balagué, F | 1 |
Waldburger, M | 1 |
Stiefelhagen, P | 1 |
Wiegand, G | 1 |
Haber, HP | 1 |
Binder, G | 1 |
Kaulitz, R | 1 |
Hofbeck, M | 1 |
Cohen-Lehman, J | 1 |
Dahl, P | 1 |
Eskes, SA | 1 |
Gassanov, N | 1 |
Dietlein, M | 1 |
Caglayan, E | 1 |
Erdmann, E | 1 |
Er, F | 1 |
González Oliva, JC | 1 |
Saurina i Solé, A | 1 |
Pou Potau, M | 1 |
Salas Gama, KR | 1 |
Ramírez de Arellano Serna, M | 1 |
Trudel, K | 1 |
Sanatani, S | 1 |
Panagiotopoulos, C | 1 |
Kessenich, CR | 1 |
Higgs, DA | 1 |
Padmanabhan, H | 1 |
Coceani, M | 1 |
Molinaro, S | 1 |
Scalese, M | 1 |
Landi, P | 1 |
Carpeggiani, C | 1 |
L'abbate, A | 1 |
Iervasi, G | 1 |
Pingitore, A | 1 |
Lee, KF | 1 |
Lee, KM | 1 |
Fung, TT | 1 |
Ahmed, S | 1 |
Wiesfeld, AC | 1 |
Van Veldhuisen, DJ | 1 |
Capraro, J | 1 |
Thalmann, S | 1 |
Nakashima, T | 1 |
Takasugi, N | 1 |
Kubota, T | 1 |
Takasugi, M | 1 |
Kanamori, H | 1 |
Ushikoshi, H | 1 |
Hattori, A | 1 |
Aoyama, T | 1 |
Kawasaki, M | 1 |
Nishigaki, K | 1 |
Takemura, G | 1 |
Minatoguchi, S | 1 |
Monzani, F | 1 |
Puzzovivo, A | 1 |
Guida, P | 1 |
Forleo, C | 1 |
Ciccone, MM | 1 |
Catanzaro, R | 1 |
Tafaro, E | 1 |
Licchelli, B | 1 |
Giagulli, VA | 1 |
Guastamacchia, E | 1 |
Favale, S | 1 |
Rizzo, LF | 1 |
Bruno, OD | 1 |
Zosin, I | 1 |
Balaş, M | 1 |
Marshall, LL | 1 |
Al-Sarraf, A | 1 |
Li, M | 1 |
Frohlich, J | 1 |
Leung, AM | 1 |
Braverman, LE | 11 |
Larrain, S | 1 |
Rinella, ME | 1 |
Wang, JY | 1 |
Hwang, B | 1 |
Lin, YF | 1 |
Chen, JD | 1 |
Biondi, B | 1 |
Martin, CM | 1 |
Nishikawa, M | 1 |
Toyoda, N | 1 |
Nomura, E | 1 |
Cai, Y | 1 |
Tang, L | 1 |
Maby-Mottet, V | 1 |
Ollo, D | 1 |
Meyer, P | 1 |
Alyan, O | 1 |
Arda, K | 1 |
Ozdemir, O | 1 |
Acu, B | 1 |
Soylu, M | 1 |
Demirkan, D | 1 |
Casañ Fernández, R | 1 |
Juan Vidal, O | 1 |
Barbisan, JN | 1 |
Fuchs, FD | 1 |
D'Agord Schaan, B | 1 |
Perazza, L | 1 |
Scardi, S | 2 |
Middleton, SC | 1 |
Spencer, AP | 1 |
Hermida, JS | 1 |
Jarry, G | 1 |
Tcheng, E | 1 |
Moullart, V | 1 |
Arlot, S | 1 |
Rey, JL | 1 |
Schvartz, C | 1 |
Bednarek-Tupikowska, G | 1 |
Filus, A | 1 |
Kuliczkowska, J | 1 |
Bugajski, J | 1 |
Lomenick, JP | 1 |
Jackson, WA | 1 |
Backeljauw, PF | 1 |
Serdiuk, SE | 4 |
Bakalov, SA | 4 |
Soboleva, VA | 1 |
Golitsin, SP | 1 |
Molashenko, NV | 4 |
Platonova, NM | 4 |
Sviridenko, NIu | 4 |
Zyśko, D | 1 |
Gajek, J | 1 |
Simkó, J | 1 |
Barta, K | 1 |
Szabó, Z | 1 |
Varga, E | 1 |
Nagy, E | 1 |
Lorincz, I | 1 |
Pantos, C | 1 |
Mourouzis, I | 1 |
Malliopoulou, V | 1 |
Paizis, I | 1 |
Tzeis, S | 1 |
Moraitis, P | 1 |
Sfakianoudis, K | 1 |
Varonos, DD | 1 |
Cokkinos, DV | 1 |
Golitsyn, SP | 3 |
Sitina, VK | 1 |
Kotkina, TI | 1 |
Ross, IL | 1 |
Marshall, D | 1 |
Okreglicki, A | 1 |
Isaacs, S | 1 |
Levitt, NS | 1 |
Basaria, S | 1 |
Cooper, DS | 1 |
Schlegel, A | 1 |
Vinzio, S | 1 |
Brafin-Busch, MS | 1 |
Schlienger, JL | 1 |
Goichot, B | 1 |
Sato, K | 3 |
Nichols, N | 1 |
Schaan, BD | 1 |
Cunha, CP | 1 |
Francisconi, A | 1 |
Zottis, B | 1 |
Brum, G | 1 |
Bruch, RS | 1 |
Gus, M | 1 |
Pinto Marín, A | 1 |
Ríos Blanco, JJ | 1 |
García de Paso Mora, P | 1 |
Pascual Pareja, JF | 1 |
Mateos, M | 1 |
Sendino Revuelta, A | 1 |
Vázquez Rodríguez, JJ | 1 |
Camarero, V | 1 |
Llata, L | 1 |
Ruiz, E | 1 |
Torres, G | 1 |
Porsche, R | 1 |
Brenner, ZR | 1 |
Ozawa, Y | 1 |
Horiuchi, R | 1 |
Yamamoto, K | 1 |
Diehl, LA | 1 |
Romaldini, JH | 1 |
Graf, H | 1 |
Albino, CC | 1 |
Kucharczyk, P | 2 |
Michałkiewicz, D | 2 |
Kucharczyk, A | 2 |
Niinikoski, H | 1 |
Hämäläinen, AM | 1 |
Ekblad, H | 1 |
Soukka, H | 1 |
Gupta, R | 2 |
Varma, Y | 1 |
Yadav, BS | 1 |
Gupta, S | 1 |
Gupta, N | 1 |
Saikia, UK | 1 |
Saikia, M | 1 |
Franklyn, JA | 3 |
Gammage, MD | 3 |
Batcher, EL | 1 |
Tang, XC | 1 |
Singh, BN | 4 |
Singh, SN | 1 |
Reda, DJ | 1 |
Hershman, JM | 1 |
Shi, RQ | 1 |
Lee, JK | 1 |
Hayashi, Y | 1 |
Takeuchi, Y | 1 |
Kambe, F | 1 |
Futaki, S | 1 |
Seo, H | 1 |
Murata, Y | 1 |
Kodama, I | 1 |
Nakazawa, T | 1 |
Murata, S | 1 |
Kondo, T | 1 |
Nakamura, N | 1 |
Yamane, T | 1 |
Iwasa, S | 1 |
Katoh, R | 1 |
Mikosch, P | 1 |
Patte, D | 1 |
Léger, FA | 1 |
Savoie, JC | 2 |
Ménage, JJ | 1 |
Samson, Y | 1 |
Nivet, M | 1 |
Goulon, M | 1 |
Beck-Peccoz, P | 1 |
Piscitelli, G | 1 |
Giani, P | 1 |
Volpi, A | 1 |
Maggioni, AP | 1 |
Landolina, M | 1 |
Tognoni, G | 1 |
Nademanee, K | 2 |
McKenna, WJ | 2 |
Rowland, E | 2 |
Krikler, DM | 2 |
Posner, J | 1 |
Sobel, RJ | 1 |
Glick, S | 1 |
Safran, M | 6 |
Rajatanavin, R | 1 |
Lenziardi, M | 4 |
Fay, M | 1 |
Pacchiarotti, A | 1 |
Aronin, N | 1 |
Macchia, E | 1 |
Haffajee, C | 1 |
Sanmartí, A | 3 |
Permanyer-Miralda, G | 1 |
Castellanos, JM | 2 |
Foz-Sala, M | 1 |
Galard, RM | 1 |
Soler-Soler, J | 1 |
Weissel, M | 2 |
Weber, H | 1 |
Harris, L | 1 |
Erba, SM | 1 |
Puletti, M | 1 |
Cornacchia, R | 1 |
Curione, M | 1 |
Borgia, C | 1 |
Cramarossa, L | 1 |
Amico, JA | 1 |
Richardson, V | 1 |
Alpert, B | 1 |
Herrmann, J | 1 |
Emrich, D | 1 |
Kemper, F | 1 |
Köbberling, J | 1 |
Pickardt, RC | 1 |
Stubbe, P | 1 |
Trip, MD | 5 |
Düren, DR | 1 |
Lie, KI | 1 |
Touber, JL | 2 |
Borghi, A | 1 |
Gheri, RG | 2 |
Pratesi, E | 1 |
Bassi, F | 1 |
Cappelli, G | 1 |
Paladini, S | 1 |
Brocchi, A | 1 |
Pucci, P | 1 |
Marchi, F | 1 |
Fazzini, PF | 1 |
Jonckheer, MH | 2 |
Larsen, PR | 1 |
Stäubli, M | 1 |
Bischof, P | 1 |
Wimpfheimer, C | 1 |
Studer, H | 1 |
Liechti, B | 1 |
Burger, A | 2 |
Ferrero, C | 1 |
Martin-Du Pan, RC | 1 |
Goumaz, MO | 1 |
Perrotet, C | 1 |
Magee, LA | 1 |
Downar, E | 1 |
Sermer, M | 1 |
Boulton, BC | 1 |
Allen, LC | 1 |
Koren, G | 1 |
Tereshchenko, IV | 2 |
Tsepelev, VV | 2 |
Liu, PM | 1 |
Zhang, XM | 1 |
Wu, W | 2 |
Li, JM | 1 |
Tang, Y | 1 |
Cesarone, CF | 1 |
Scarabelli, L | 1 |
Giannoni, P | 1 |
Orunesu, M | 1 |
De Catte, L | 2 |
De Wolf, D | 2 |
Smitz, J | 3 |
Bougatef, A | 2 |
De Schepper, J | 3 |
Foulon, W | 2 |
Feigl, D | 2 |
Gilad, R | 2 |
Tuwal, M | 1 |
Nakash, I | 1 |
Katz, E | 2 |
Hensley, CB | 1 |
Bersohn, MM | 1 |
Sarma, JS | 1 |
McDonough, AA | 1 |
Grasso, L | 1 |
Brogioni, S | 2 |
Ivanova, ES | 1 |
Gøtzsche, LB | 1 |
Orskov, H | 1 |
Khanderia, U | 1 |
Jaffe, CA | 1 |
Theisen, V | 1 |
Allain, P | 1 |
Berre, S | 1 |
Krari, N | 1 |
Lainé-Cessac, P | 1 |
Le Bouil, A | 1 |
Barbot, N | 1 |
Rohmer, V | 1 |
Bigorgne, JC | 1 |
van Dam, EW | 1 |
Prummel, MF | 1 |
Nikkels, RE | 1 |
Roti, E | 3 |
Minelli, R | 3 |
Gardini, E | 3 |
Bianconi, L | 3 |
Unger, J | 6 |
Lambert, M | 2 |
Denayer, P | 1 |
Mallaret, M | 1 |
Mezin, P | 1 |
Chartier, A | 1 |
Caron, P | 2 |
Ahmad, S | 1 |
Liu, P | 1 |
Fei, L | 1 |
Li, J | 1 |
Wang, J | 1 |
Zhang, X | 1 |
Manetti, L | 1 |
Wilhelm, JM | 1 |
Saraceni, O | 1 |
Kieffer, P | 1 |
Kabadi, UM | 1 |
Biddle, JR | 1 |
Newman, CM | 1 |
Price, A | 1 |
Davies, DW | 1 |
Gray, TA | 1 |
Weetman, AP | 1 |
Wolff, J | 1 |
Gandy, J | 1 |
Wonko, N | 1 |
Kantoch, MJ | 1 |
Grosso, S | 1 |
Berardi, R | 1 |
Cioni, M | 1 |
Morgese, G | 1 |
Bosch, RF | 1 |
Li, GR | 1 |
Gaspo, R | 1 |
Nattel, S | 2 |
Hain, SF | 1 |
O'Doherty, MJ | 1 |
Mariotti, S | 5 |
Loviselli, A | 3 |
Murenu, S | 1 |
Sau, F | 1 |
Valentino, L | 1 |
Mandas, A | 1 |
Vacquer, S | 1 |
Balestrieri, A | 1 |
Lai, ME | 1 |
Pitsiavas, V | 1 |
Smerdely, P | 1 |
Boyages, SC | 1 |
Lahera Vargas, M | 1 |
de Luis Román, D | 1 |
Hervilla Ezquerra, S | 1 |
Maldonado Castro, G | 1 |
Zurita Sepúlveda, P | 1 |
Gerber, H | 1 |
Noth, D | 1 |
Miyakawa, M | 1 |
Eto, M | 1 |
Inaba, T | 1 |
Matsuda, N | 2 |
Shiga, T | 2 |
Ohnishi, S | 1 |
Kasanuki, H | 2 |
Vandergheynst, F | 1 |
Liénart, F | 1 |
Ducobu, J | 1 |
Weston, SN | 1 |
Weston, CF | 1 |
Odelola, AT | 1 |
Erdoğan, MF | 1 |
Güleç, S | 1 |
Tutar, E | 1 |
Güldal, M | 1 |
Başkal, N | 1 |
Erdoğan, G | 1 |
Chuang, CL | 1 |
Chern, MS | 1 |
Chang, SC | 1 |
Toft, AD | 1 |
Boon, NA | 1 |
Alonso Hernández, P | 1 |
Otero López, MJ | 1 |
Calderón Guadilla, RM | 1 |
Domínguez-Gil Hurlé, A | 1 |
Ojamaa, K | 1 |
Rouleau, F | 1 |
Baudusseau, O | 1 |
Dupuis, JM | 1 |
Victor, J | 1 |
Geslin, P | 1 |
Vanbesien, J | 1 |
Casteels, A | 1 |
De Bock, S | 1 |
Markou, K | 1 |
Georgopoulos, N | 1 |
Kyriazopoulou, V | 1 |
Vagenakis, AG | 1 |
Sandhu, RS | 1 |
Davies, PH | 1 |
Wakaumi, M | 1 |
Shoda, M | 1 |
Hagiwara, N | 1 |
Preobrazhenskiĭ, DV | 1 |
Ryndina, MG | 1 |
Blizniak, GV | 1 |
Léger, AF | 1 |
Pucciarelli, G | 1 |
Caso, P | 1 |
Jacono, A | 1 |
Darwiche, A | 1 |
Vanlieferinghen, P | 1 |
Lemery, D | 1 |
Paire, M | 1 |
Lusson, JR | 1 |
Salvi, M | 1 |
Gavaruzzi, G | 1 |
Ugolotti, G | 1 |
Neri, TM | 1 |
Sinadinović, J | 1 |
Cvejić, D | 1 |
Savin, S | 1 |
Mićić, JV | 1 |
Matsumura, LK | 1 |
Born, D | 1 |
Kunii, IS | 1 |
Franco, DB | 1 |
Maciel, RM | 1 |
Hijazi, ZM | 1 |
Rosenfeld, LE | 1 |
Copel, JA | 1 |
Kleinman, CS | 1 |
Plomp, TA | 3 |
Vulsma, T | 1 |
de Vijlder, JJ | 1 |
Suárez, S | 1 |
Cárdenes, M | 1 |
Ruiz, S | 1 |
Artiles, J | 1 |
Arkuch, A | 1 |
Delgado, J | 1 |
Aguilar Diosdado, M | 1 |
Jáen Amate, F | 1 |
Gavilán Villarejo, I | 1 |
Merino López, FJ | 1 |
Paradis, P | 1 |
Lambert, C | 1 |
Rouleau, J | 1 |
Wiersinga, W | 1 |
Kaplan, J | 1 |
Ish-Shalom, S | 1 |
Chow, CC | 1 |
Cockram, CS | 1 |
Carli, P | 1 |
De Jaureguiberry, JP | 1 |
Moreau, X | 1 |
Chagnon, A | 1 |
Reĭngardene, DI | 1 |
Sutkus, AA | 1 |
Figge, HL | 1 |
Figge, J | 2 |
Zhou, ZB | 1 |
Zaninovich, AA | 1 |
Bosco, SC | 1 |
Fernandez-Pol, AJ | 1 |
García, RV | 1 |
Gómez Sobreira, M | 1 |
Batista, J | 1 |
Moreiras, M | 1 |
Lázaro Enguis, J | 1 |
Alvarez Gándara, D | 1 |
Dluhy, RG | 1 |
Kasim, SE | 2 |
Bagchi, N | 2 |
Brown, TR | 2 |
Khilnani, S | 2 |
Jackson, K | 1 |
Steinman, RT | 1 |
Lehmann, MH | 1 |
De Rosa, G | 2 |
Corsello, SM | 2 |
Testa, A | 2 |
Callà, C | 1 |
Talajic, M | 1 |
Davies, M | 1 |
McCans, J | 1 |
Surmont, DW | 1 |
Sarot, J | 1 |
Soupart, A | 1 |
Dumont, JE | 1 |
Simonin, R | 1 |
Foresti, V | 2 |
Villa, A | 1 |
Parisio, E | 2 |
Terenzio, C | 1 |
Scolari, N | 2 |
Confalonieri, F | 1 |
Clouston, PD | 1 |
Donnelly, PE | 1 |
Salamon, E | 1 |
Rowe, RC | 1 |
Faiman, C | 1 |
Mancini, A | 1 |
De Marinis, L | 1 |
Calabrò, F | 1 |
Sciuto, R | 1 |
Oradei, A | 1 |
Lippa, S | 1 |
Sandric, S | 1 |
Littarru, GP | 1 |
Barbarino, A | 1 |
Gärtner, R | 1 |
Lucas, A | 1 |
Foz, M | 2 |
Ceccarelli, C | 3 |
Lippi, F | 2 |
Piga, M | 2 |
Braverman, L | 3 |
Permanyer, G | 1 |
Hartong, R | 1 |
Lamers, WH | 1 |
Broenink, M | 1 |
van Beeren, MH | 1 |
Cecchini, L | 1 |
Hawthorne, GC | 1 |
Campbell, NP | 1 |
Geddes, JS | 1 |
Ferguson, WR | 1 |
Postlethwaite, W | 1 |
Sheridan, B | 1 |
Atkinson, AB | 1 |
van Royen, EA | 1 |
Morabito, S | 1 |
Baschieri, L | 1 |
Pinchera, A | 5 |
Endert, E | 1 |
Verhaest-de Jong, N | 1 |
Burger, AG | 1 |
De Nayer, P | 1 |
Beckers, C | 1 |
Fragu, P | 2 |
Schlumberger, M | 2 |
Davy, JM | 1 |
Slama, M | 1 |
Berdeaux, A | 1 |
Hyatt, RH | 1 |
Sinha, B | 1 |
Vallon, A | 1 |
Bailey, RJ | 1 |
Martin, A | 1 |
Verhaaren, H | 1 |
Deneyer, M | 1 |
Sacre-Smits, L | 1 |
Bretremieux, P | 1 |
Laurent, M | 1 |
Almange, C | 1 |
Lefrançois, C | 1 |
Weir, SJ | 1 |
Ueda, CT | 1 |
Sheppard, MC | 1 |
Piketty, ML | 1 |
Talbot, JN | 1 |
Askienazy, S | 1 |
Milhaud, G | 1 |
Van Reeth, O | 1 |
Decoster, C | 1 |
Enia, G | 1 |
Costante, G | 1 |
Catalano, C | 1 |
Zoccali, C | 1 |
Maggiore, Q | 1 |
Valenzuela, Mde L | 1 |
Pineda, G | 2 |
Bambini, G | 2 |
Logan, SD | 1 |
Costigan, DC | 1 |
Holland, FJ | 1 |
Daneman, D | 1 |
Hesslein, PS | 1 |
Vogel, M | 1 |
Ellis, G | 1 |
Ciani, F | 1 |
Pandullo, C | 1 |
Padrini, R | 1 |
Pivotti, F | 1 |
Carini, L | 1 |
Lovagnini-Scher, CA | 1 |
Fang, SL | 1 |
Albert, SG | 1 |
Alves, LE | 1 |
Rose, EP | 1 |
Abalovich, MS | 1 |
Gutiérrez, S | 1 |
Aszenmil, G | 1 |
Guitelman, A | 1 |
Mechlis, S | 1 |
Lubin, E | 1 |
Laor, J | 1 |
Margaliot, M | 1 |
Strasberg, B | 1 |
Zimmerman, J | 1 |
Dunn, M | 1 |
Gómez, JM | 1 |
Cequier, A | 1 |
Pérez Ayuso, MJ | 1 |
Gausi, C | 1 |
Soler, J | 1 |
Mangiardi, L | 1 |
Gaita, F | 1 |
Brun, S | 1 |
Presbitero, P | 1 |
Borowski, GD | 1 |
Garofano, CD | 1 |
Rose, LI | 1 |
Spielman, SR | 1 |
Rotmensch, HR | 1 |
Greenspan, AM | 1 |
Horowitz, LN | 1 |
Ben-Chetrit, E | 1 |
Ackerman, Z | 1 |
Eliakim, M | 1 |
Marcus, FI | 1 |
Rodríguez Espinosa, J | 1 |
Codina Marcet, M | 1 |
Domínguez, JM | 1 |
Ordóñez Llanos, J | 1 |
Brami, JL | 1 |
Schlaeffer, F | 1 |
Sobel, R | 1 |
Meruane, J | 1 |
Valenzuela, MA | 1 |
Bianchi, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Hypothyroidism After the TAVI Procedure in Elderly Patients[NCT04831957] | 20 participants (Anticipated) | Interventional | 2021-07-26 | Recruiting | |||
Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
81 reviews available for amiodarone and Hypothyroidism
Article | Year |
---|---|
Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypo | 2023 |
Prevalence of Amiodarone Induced Hypothyroidism and Hyperthyroidism in Patients with Heart Diseases: A Systematic Review and Meta-Analysis.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Prevalence | 2023 |
AMIODARONE AND THYROID DYSFUNCTION.
Topics: Amiodarone; Humans; Hypothyroidism; Iodine; Thyroiditis; Thyrotoxicosis; Thyroxine | 2022 |
Amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; History, 21st Century; Hypothyroidism; Practice Guidelines as To | 2021 |
[Iodine-induced thyroid dysfunction].
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Iodine | 2021 |
[Amiodarone-induced thyrotoxicosis].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Gland; Thyrotoxicosis | 2017 |
The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers; Diagnosis, Differential; Early | 2017 |
Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches.
Topics: Amiodarone; Chronic Disease; Heart Failure; Humans; Hyperthyroidism; Hypothyroidism | 2018 |
Topics: Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Humans; Hyperthyroidism; Hypothyroidism | 2018 |
Thyroid and Eye: Where They Meet in Clinical Practice.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Diabetic Retinopathy; Eye; Eye Dise | 2020 |
Amiodarone-induced thyroid dysfunction in the developmental period: prenatally, in childhood, and adolescence - case reports and a review of the literature.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Humans; Hypothyroid | 2019 |
[Effect of amiodarone on the thyroid function and safety of the therapy--what's new].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Causality; Comorbidity; Dronedarone; Human | 2012 |
Amiodarone-induced thyroid dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; Male; Middle Aged; Thyroid Funct | 2015 |
[Every sixth patient in amiodarone treatment develops thyrotoxicosis or hypothyreosis].
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Drug Prescriptions; Humans; Hypothyroidism; Risk Fa | 2014 |
[Amiodarone and the thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hyperthyroidism; Hypothyroidism; Ta | 2014 |
Amiodarone and the thyroid.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Glucocorticoids; Humans; Hypothyroidism; Male; Mid | 2015 |
[Clinical procedure in amiodarone-induced thyroid dysfunction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Risk Factors; Thyroid Diseases; Thyroid | 2016 |
Effect of excess iodine intake on thyroid on human health.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; Hypothyroidi | 2017 |
Benzofuran derivatives and the thyroid.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzofurans; Dronedarone; Humans; Hypothyroidism; Recep | 2009 |
The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Heart; Heart Rate; Humans; Hypothyroidism; Myosin Heavy | 2010 |
Effects of amiodarone therapy on thyroid function.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Dronedarone; Humans; Hypothyroidism; Iodine; Thyroid Di | 2010 |
Amiodarone and thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Female; Humans; Hypothyroidism; Male; Pregnancy; Pr | 2009 |
[Amiodarone-induced thyroid gland dysfunctions].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Follow-Up Studies; Half-Life; Humans; Hyperth | 2010 |
Amiodarone and thyroid dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Continuity of Patient Care; Glucocorticoids; | 2010 |
[Amiodarone and thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Hormone Replacement Therapy; Humans; Hyperthyroidism; Hypothyroi | 2011 |
[Amiodarone and thyroid dysfunction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Hypothyroidism; Iodine | 2012 |
Gastrointestinal bleeding and possible hypothyroidism.
Topics: Aged, 80 and over; Amiodarone; Anemia; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroid | 2012 |
Amiodarone and the thyroid: a 2012 update.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hypothyroidism; Thyroxine | 2012 |
Iodine-induced thyroid dysfunction.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Dietary Supplements; | 2012 |
A myriad of pathways to NASH.
Topics: Amiodarone; Anti-Retroviral Agents; Bacterial Infections; Cannabis; Diet; Fatty Liver; Genetic Disea | 2012 |
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
Thyroid hormone-regulated cardiac gene expression and cardiovascular disease.
Topics: Amiodarone; Animals; Cardiovascular Diseases; Cytokines; Gene Expression Regulation; Humans; Hypothy | 2002 |
[Amiodarone and thyroid dysfunction: a pending problem].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Diseases | 2003 |
[Amiodarone and the thyroid gland].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Glucocorticoids; Humans; Hy | 2004 |
Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Congenital Hypothyroidism; Female; Fetal Diseases; Humans; Hypot | 2004 |
[Thyroid and cardiovascular disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Artery B | 2004 |
[Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Heart Failure; Hum | 2004 |
Amiodarone and the thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Gland | 2005 |
[Cardiac consequences of clinical dysthyroidism. Pathophysiological, clinical, and epidemiologic data].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; | 2005 |
[Drug (amiodarone)-induced thyroid disease].
Topics: Amiodarone; Hormone Replacement Therapy; Humans; Hypothyroidism; Perchlorates; Prednisolone; Thyroto | 2005 |
Hypothyroidism and cardiovascular disease.
Topics: Amiodarone; Cardiovascular Agents; Cardiovascular Diseases; Drug Interactions; Humans; Hypothyroidis | 2005 |
Amiodarone-induced thyroid dysfunction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Care; Diagnosis, Differentia | 2006 |
[Iodine-induced hypothyroidism].
Topics: Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Humans; Hypothyroidism; Iodine; Prognos | 2006 |
[Hypothyroidisms induced by drugs].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Endocrine Disruptors; Humans; Hypothyroidism | 2006 |
[Drugs affecting thyroid--part II].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; Iodine; Lithium; Male; Thyroid F | 2006 |
Cardiovascular changes in thyroid disorder.
Topics: Amiodarone; Cardiovascular Diseases; Humans; Hyperthyroidism; Hypothyroidism; Risk Factors; Thyroid | 2006 |
Drug-induced thyroid disorders.
Topics: Amiodarone; Dexamethasone; Enzyme Inhibitors; Humans; Hypothyroidism; Interferon-alpha; Lithium Comp | 2006 |
[Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Follow-Up Studies; Humans; Hyperthyr | 2008 |
[Amiodarone and thyroid function].
Topics: Amiodarone; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Gland; Thyroid Hormones | 1984 |
Amiodarone: the experience of the past decade.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1983 |
Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones.
Topics: Adolescent; Amiodarone; Animals; Brain; Cholecystography; Feedback; Female; Graves Disease; Humans; | 1982 |
Amiodarone-induced thyroid dysfunction.
Topics: Adult; Aged; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Male; Tachycardia, Ventricular; Th | 1993 |
[Effects of amiodarone on thyroid function].
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Humans; Hyperthyroidism; Hypothyroidism | 1995 |
[Amiodarone and thyroid: pharmacologic and toxic effects].
Topics: Amiodarone; Drug Monitoring; Humans; Hypothyroidism; Thyroid Gland; Thyroid Hormones; Thyrotoxicosis | 1996 |
[Amiodarone-induced hypothyroidism followed by hyperthyroidism. Apropos of 2 new cases].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Mid | 1996 |
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Protocols; Humans; Hypothyroidism; Thyroid Function Tes | 1998 |
Perchlorate and the thyroid gland.
Topics: Amiodarone; Animals; Enzyme Inhibitors; Humans; Hypothyroidism; Iodide Peroxidase; Iodides; Kinetics | 1998 |
[Amiodarone and the thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Iodine; Thyroid Gland; Thyrotoxicosis | 1999 |
[Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Contraindications; Hormone Repla | 1999 |
[Amiodarone and thyroid disorders--prospective study and review of the literature].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; | 1999 |
HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; HLA Antigens; HLA-B Antigens; HLA-B40 Antigen; HLA-C Antigens; H | 2000 |
Thyroid disease and the heart.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Heart Diseases; Humans; Hyperth | 2000 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Lactation; Maternal-Fetal Exchange; Ner | 2001 |
The effects of amiodarone on the thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Hormone Replacement Therapy; Humans; | 2001 |
Iodine-Induced hypothyroidism.
Topics: Amiodarone; Drug Synergism; Female; Goiter; Humans; Hypothyroidism; Infant, Newborn; Iodides; Iodine | 2001 |
The various effects of amiodarone on thyroid function.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Male; Pregnancy; Thyroid Diseases; Thyroid Gland; Thyrot | 2001 |
Amiodarone induced thyroid dysfunction: pathophysiology, diagnosis and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Function Tests; Thyroid Gland; T | 2001 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
[Iodine containing drugs and thyroid gland function. A diagnostic and therapeutic problem].
Topics: Amiodarone; Austria; Goiter, Endemic; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Sodium Chlori | 1991 |
Thyroid disorders induced by lithium and amiodarone: an overview.
Topics: Amiodarone; Animals; Goiter; Humans; Hypothyroidism; Lithium; Thyroid Diseases; Thyroid Hormones; Th | 1990 |
Effects of iodine on thyroid function in man.
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Gland | 1991 |
[The side effects of amiodarone on thyroid function].
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Structure-Activity Relationship; Thyroid Gland | 1990 |
[Amiodarone and thyroid: the Janus effect].
Topics: Adaptation, Physiological; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Glan | 1990 |
The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations.
Topics: Amiodarone; Chemical Phenomena; Chemistry; Humans; Hyperthyroidism; Hypothyroidism; Myocardium; Thyr | 1990 |
[Adverse and toxic reaction to amiodarone and its interaction with other drugs].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Pneumonia | 1990 |
[Amiodarone-induced thyroid pathology].
Topics: Amiodarone; Antithyroid Agents; Female; Humans; Hyperthyroidism; Hypothyroidism; Lithium; Male; Midd | 1987 |
[Effects of amiodarone on thyroid gland function].
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Function Tests | 1989 |
[Amiodarone and thyroid function].
Topics: Amiodarone; Goiter; Humans; Hypothyroidism; Thyroid Gland; Thyroid Hormones; Thyronines | 1987 |
[Thyroid function and amiodarone. Consequences on dysthyroidism testing].
Topics: Amiodarone; Animals; Benzofurans; Biotransformation; Humans; Hyperthyroidism; Hypothyroidism; Iodine | 1985 |
Clinical use of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Electrophysiology; Heart; Humans; H | 1985 |
5 trials available for amiodarone and Hypothyroidism
Article | Year |
---|---|
Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Austria; Female; Humans; Hypothyroidism; Incidence; Male; | 2008 |
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Female; Humans; Hyper | 2007 |
Multicenter controlled observation of a low-dose regimen of amiodarone for treatment of severe ventricular arrhythmias. Collaborative Group for Amiodarone Evaluation.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Clinical Trials as To | 1984 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
Effect of amiodarone on serum T4 and T3 levels in hyperthyroid patients treated with methimazole.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Double-Blind Method; Female; Humans; Hypothyroidism; Met | 1987 |
202 other studies available for amiodarone and Hypothyroidism
Article | Year |
---|---|
Polypharmacy Is Associated With Amiodarone-Induced Hypothyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Drug Interactio | 2021 |
Editorial commentary: The striking prevalence of amiodarone induced hypothyroidism: an endocrinologist's perspective.
Topics: Amiodarone; Endocrinologists; Humans; Hypothyroidism; Prevalence | 2023 |
Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; Electrocardiography; Human | 2022 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Time-to-onset analysis of amiodarone-associated thyroid dysfunction.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; Fem | 2020 |
Myxedema coma: four patients diagnosed at the Internal Medicine Department of the Dr. Negrin University Hospital in Spain.
Topics: Aged; Aged, 80 and over; Amiodarone; Coma; Female; Hormone Replacement Therapy; Hospitals, Universit | 2019 |
Pharmacologically induced thyreopathy in patients with cardiovascular disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Diseases; Humans; Hyperthyroidism; Hypothyroidism | 2020 |
An unexpected cause of residual renal function loss.
Topics: Amiodarone; Disease Progression; Glomerular Filtration Rate; Humans; Hypothyroidism; Kidney Failure, | 2020 |
Amiodarone-Associated Myxedema Coma.
Topics: Aged; Amiodarone; Coma; Humans; Hypothyroidism; Male; Myxedema; Thyroid Function Tests | 2020 |
Amiodarone and hypothyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Male; Tachycardia, Ventricular | 2021 |
The clinical value of regular thyroid function tests during amiodarone treatment.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Hu | 2017 |
Response: Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio; could a drug-induced toxicity be regulating exposure to the offending agent?
Topics: Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Drug-Related Side Effects and Adverse Reactions; Hu | 2017 |
Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio: could a drug-induced toxicity be regulating exposure to the offending agent?
Topics: Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Drug-Related Side Effects and Adverse Reactions; Hu | 2017 |
Acquired Hypothyroidism in a Newborn Treated with Amiodarone in the First Week of Life.
Topics: Amiodarone; Anti-Arrhythmia Agents; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Prenata | 2017 |
Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; | 2018 |
Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coma; Female; Hematoma; Humans; Hypothermia; Hypothyroidism; Mid | 2019 |
Patterns of amiodarone-induced thyroid dysfunction in infants and children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Developmental Disabilities; Early D | 2019 |
Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Infant, Ne | 2019 |
[Thyroid dysfunction and amiodarone].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Drug Combinations; | 2013 |
[A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Female; Fibrosis; Hu | 2013 |
An unexpected side-effect of a commonly used drug.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arthralgia; Biopsy; Drug Eruptions; Drug Substitution; Dys | 2013 |
[The "blue man"].
Topics: Amiodarone; Anti-Arrhythmia Agents; Eye; Humans; Hyperthyroidism; Hypothyroidism; Lung; Male; Middle | 2013 |
Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Body Mass Index; Cohort Studies; | 2014 |
Results of preventive radioiodine therapy in euthyroid patients with history of hyperthyroidism prior to administration of amiodarone with permanent atrial fibrillation--a preliminary study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Rela | 2014 |
Amiodarone-related thyroid dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Failure; Humans; Hypothyroidism; Thyr | 2014 |
Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Hypothyr | 2014 |
Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Analysis of Variance; Asia; Australia; Chi-Squa | 2015 |
Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease.
Topics: Adolescent; Adult; Amiodarone; Asian People; Female; Follow-Up Studies; Heart Defects, Congenital; H | 2015 |
Age and thyroid hormone replacement delays the recovery from amiodarone-induced hypothyroidism.
Topics: Age Factors; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Hum | 2016 |
The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
Topics: Aged; Amiodarone; Diabetes Mellitus, Type 2; Female; Humans; Hypothalamo-Hypophyseal System; Hypothy | 2016 |
Adverse Reactions of Amiodarone on the Thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Risk Factors; Thyroid Gland | 2016 |
[Iodine excess induced thyroid dysfunction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Contrast Media; Humans; Hyperthyroidism; Hyp | 2016 |
Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction.
Topics: Amiodarone; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Retrospective Studies; Thyrotropi | 2017 |
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Humans; Hypothyroidism; Male; Middle Aged; Perch | 2008 |
Amiodarone-induced hypothyroidism with EPO-resistant anemia in a patient with chronic renal failure.
Topics: Aged, 80 and over; Amiodarone; Anemia; Anti-Arrhythmia Agents; Drug Resistance; Erythropoietin; Huma | 2008 |
Acute renal failure due to amiodarone-induced hypothyroidism.
Topics: Acute Kidney Injury; Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Kidney Functi | 2009 |
How frequently should a patient taking amiodarone be screened for thyroid dysfunction?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Hyperthyr | 2009 |
Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Topics: Aged; Aged, 80 and over; Amiodarone; Female; Follow-Up Studies; Goiter; Humans; Hypothyroidism; Iodi | 2009 |
[What is your diagnosis. Myopathy due to hypothyroidism aggravated by amiodarone].
Topics: Accidental Falls; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagno | 2009 |
[Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Atrial Fi | 2009 |
Tital page - ultrasound findings in newborns with amiodarone-induced hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Follow-Up Studies; Humans; Hypothyroidism; Infant, Newborn; Infa | 2009 |
[Difficult-to-treat atrial fibrillation in a patient on haemodialysis].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Bradycardia; Calcium | 2010 |
Severe amiodarone-induced hypothyroidism in an infant.
Topics: Amiodarone; Female; Heart Defects, Congenital; Humans; Hypothyroidism; Infant; Thyroid Function Test | 2011 |
Understanding amiodarone-induced hypothyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Insufficiency; Atrial Fibrillation; Female; H | 2010 |
Thyroid hormone, amiodarone therapy, and prognosis in left ventricular systolic dysfunction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Female; Follow | 2011 |
Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; China; Female; Humans; Hypothyro | 2010 |
Determinants and outcome of amiodarone-associated thyroid dysfunction.
Topics: Adult; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Databases, Factu | 2011 |
Thyroxine monotherapy without amiodarone enhances atrial fibrillation recurrences in amiodarone-induced hypothyroidism.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Comb | 2011 |
'False-positive' intrathoracic impedance monitor alarm caused by amiodarone-induced hypothyroidism in a patient with cardiac resynchronization therapy-defibrillator.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; Cardiography, Impedance | 2012 |
Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Cohort Studies; Female; Follow-Up Studies | 2012 |
Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Female; Goiter; Humans; Hypothyroidi | 2012 |
Statin resistant dyslipidemia in a patient treated with amiodarone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cholesterol, LDL; Drug Resistance; Fluorobenzenes; Humans | 2011 |
Development of refractory ascites during amiodarone therapy in a hemodialysis patient with nephrogenic and cardiogenic ascites.
Topics: Aged; Amiodarone; Ascites; Female; Heart Failure; Humans; Hypothyroidism; Kidney Failure, Chronic; P | 2012 |
Thyroid dysfunction and the elderly patient: a primer for pharmacists.
Topics: Aged; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Pharmacists; Thyroid Diseases; Thyroid Gl | 2012 |
[Hypothyroidism].
Topics: Amiodarone; Humans; Hypothyroidism; Iodine; Molecular Targeted Therapy | 2012 |
Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis.
Topics: Acute Kidney Injury; Adult; Amiodarone; Creatine Kinase; Female; Humans; Hypothyroidism; Kidney Func | 2013 |
[Amiodarone and thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Drug Monitoring; Glucocorticoids; Humans; Hy | 2012 |
Index of suspicion.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Cranial Nerve Neoplasms; Digoxin; Down Syndrome; D | 2002 |
Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
Topics: Adult; Aged; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Diagnosis, Differential; Female; H | 2003 |
[Hypothyroidism due to amiodarone: importance of monitoring].
Topics: Amiodarone; Humans; Hypothyroidism; Thyroxine | 2003 |
Prevalence of thyroid dysfunction in patients with acute atrial fibrillation attended at a cardiology emergency room.
Topics: Acute Disease; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cross-Sectional Studies; Female; Hum | 2003 |
Assessment of hypothyroidism in patients with chronic heart failure.
Topics: Aged; Amiodarone; Diagnostic Errors; Female; Heart Failure; Humans; Hypothyroidism; Male; Middle Age | 2004 |
[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Hea | 2004 |
[Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antithyroid Agents; Data Interpretatio | 2004 |
Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1.
Topics: Adaptation, Physiological; Amiodarone; Animals; Calcium-Transporting ATPases; Dronedarone; Eating; G | 2005 |
[Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Rate; Humans; Hypothyroidism; Male; Middle A | 2005 |
[Lipid blood spectrum in patients with amiodarone associated hypothyroidism. Effect of replacement therapy with L-thyroxine].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cholesterol; Female; Follow-Up Studies; Humans; Hypothyroi | 2005 |
Amiodarone-induced thyroid dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; | 2005 |
Amiodarone versus sotalol for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hyperthyroidism; Hypothyroidism | 2005 |
[Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hypothyroidism; Inci | 2005 |
Amiodarone-induced thyroid dysfunction in a tertiary center in south Brazil.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Brazil; Epidemiologic Methods; Female; Humans | 2005 |
[Left pleural effusion in patient with heart failure].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hypothyroidism | 2006 |
[Plasmapheresis in amiodarone-induced hyperthyroidism].
Topics: Adrenergic beta-Antagonists; Aged; Agranulocytosis; Amiodarone; Anti-Arrhythmia Agents; Antithyroid | 2006 |
Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Drug Administration Sc | 2006 |
[The effects of amiodaron on the thyroid function].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Disease | 2006 |
Neonatal hypothyroidism after amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Fetal Diseases; Fetal Heart; Humans; Hypothyroidism; Infant, New | 2007 |
Treatment of amiodarone-associated thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carbimazole; Hormone Replacement Therapy; Humans; Hypothyr | 2007 |
Long-term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blotting, Northern; Cluster Analysis; Disease Models, A | 2008 |
Histopathology of the thyroid in amiodarone-induced hypothyroidism.
Topics: Aged; Amiodarone; Amyloidosis; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; Multiple Myel | 2008 |
[Thyrotoxicosis, then hypothyroidism caused by iodine overload (amiodarone) associated with neuropathy. Failure of plasma exchange].
Topics: Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; Peripheral Ne | 1983 |
Adverse reactions during treatment with amiodarone hydrochloride.
Topics: Amiodarone; Benzofurans; Female; Humans; Hypothyroidism; Middle Aged; Peripheral Nervous System Dise | 1983 |
Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Iodides; Mal | 1983 |
Effect of amiodarone on thyroid hormone economy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1984 |
Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Goiter; Heart Diseases; Humans; Hyperthyroidism; Hypot | 1984 |
Chronic administration of amiodarone and thyroid function: a follow-up study.
Topics: Adult; Aged; Amiodarone; Benzofurans; Chronic Disease; Coronary Disease; Female; Follow-Up Studies; | 1984 |
Amiodarone-induced relative pituitary insensitivity.
Topics: Amiodarone; Benzofurans; Humans; Hypothyroidism; Pituitary Gland | 1984 |
Side effects and possible contraindications of amiodarone use.
Topics: Aged; Alanine Transaminase; Amiodarone; Aspartate Aminotransferases; Benzofurans; Corneal Diseases; | 1983 |
[Incidence of undesirable effects in long-term treatment with amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Eye; Female; Heart Rate; Humans; Hyperthyroidism; | 1983 |
Clinical and chemical assessment of thyroid function during therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Male; Mi | 1984 |
[Iodine overdose and its effects].
Topics: Age Factors; Amiodarone; Contrast Media; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Povidone | 1984 |
[Diagnosis of hyper- and hypothyroidism in patients using amiodarone].
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle | 1983 |
[Thyroid function in patients chronically treated with amiodarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Female; Heart Diseases; Humans; Hyperthyroidi | 1983 |
Amiodarone and the thyroid gland. A review.
Topics: Amiodarone; Animals; Benzofurans; Dogs; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Dis | 1981 |
[Amiodarone and the thyroid gland].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1981 |
[Amiodarone and thyroid function].
Topics: Aged; Amiodarone; Angina Pectoris; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged | 1980 |
[Hypothyroidism followed by hyperthyroidism under treatment with amiodarone].
Topics: Aged; Aged, 80 and over; Amiodarone; Antithyroid Agents; Female; Humans; Hyperthyroidism; Hypothyroi | 1993 |
Pregnancy outcome after gestational exposure to amiodarone in Canada.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Canada; Cohort St | 1995 |
[The effect of kordaron on thyroid function in patients with ischemic heart disease].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Male; Middle Aged; Myocardia | 1995 |
Comparison of cardiac electrophysiologic effects of experimental hypothyroidism and chronic oral amiodarone administration in dogs.
Topics: Amiodarone; Animals; Dogs; Electrocardiography; Electrophysiology; Female; Heart Conduction System; | 1994 |
Hepatic poly(ADP-ribose) polymerase activity in rat is controlled by thyroid hormones.
Topics: Amiodarone; Animals; Cell Nucleus; Homeostasis; Hypothyroidism; Kinetics; Liver; Male; Poly(ADP-ribo | 1994 |
Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Male; P | 1994 |
[Effect of low-dose amiodarone on thyroid function].
Topics: Amiodarone; Follow-Up Studies; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Gland; Thyroid Hormo | 1994 |
Amiodarone decreases Na,K-ATPase alpha 2 and beta 2 expression specifically in cardiac ventricle.
Topics: Amiodarone; Animals; Chromatography, High Pressure Liquid; Gene Expression; Heart Ventricles; Hypoth | 1994 |
Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cross-Sectional Studies; Diagnosis, Differential; Goiter | 1994 |
[Subclinical hypothyroidism in patients with ischemic heart disease].
Topics: Achilles Tendon; Aged; Amiodarone; Angina, Unstable; Arrhythmias, Cardiac; Euthyroid Sick Syndromes; | 1993 |
Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats.
Topics: Amiodarone; Animals; Binding, Competitive; Body Temperature; Calcium Channels; Cell Nucleus; Heart R | 1994 |
Use of plasma iodine assay for diagnosing thyroid disorders.
Topics: Adult; Aged; Amiodarone; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Ma | 1993 |
Treatment of amiodarone-induced hypothyroidism with potassium perchlorate.
Topics: Amiodarone; Humans; Hypothyroidism; Male; Middle Aged; Perchlorates; Potassium; Potassium Compounds; | 1993 |
Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
Topics: Adult; Aged; Amiodarone; Biopsy; Female; Humans; Hypothyroidism; Male; Middle Aged; Thyroiditis; Thy | 1993 |
Amiodarone and the thyroid: pharmacological, toxic and therapeutic effects.
Topics: Amiodarone; Humans; Hypothyroidism; Iodine; Thyroid Gland; Thyroid Hormones; Thyrotoxicosis | 1993 |
[Rhabdomyolysis in hypothyroidism. Favourable role of amiodarone].
Topics: Amiodarone; Humans; Hypothyroidism; Rhabdomyolysis | 1993 |
Sudden hypothyroidism and amiodarone-lithium combination: an interaction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Humans; Hypothyroidism; Lithium; Male; Middle | 1995 |
Effects of hypothyroidism on the vulnerability to ventricular fibrillation in dogs: a comparative study with amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Models, Anim | 1996 |
[Amiodarone and the thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Diseases; Thyroid Gland; Thyroto | 1995 |
Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amiodarone; Anti-Arrhythmia Agents; Antimanic Agents; Female; | 1997 |
Amiodarone and thyroid function.
Topics: Amiodarone; Humans; Hypothyroidism; Thyroid Hormones | 1997 |
Risks of intravenous amiodarone in neonates.
Topics: Age Factors; Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Injections, Intravenous; T | 1998 |
Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal E | 1998 |
[Hypothyroidism induced by drugs, radiotherapy, and surgery].
Topics: Amiodarone; Antithyroid Agents; Cytokines; Enzyme Inhibitors; Humans; Hypothyroidism; Lithium; Radio | 1998 |
Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Cell Separation; Delayed Rectifier P | 1999 |
Amiodarone and thyroid disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Gland | 1999 |
High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; beta-Thalassemia; Female; Humans; Hypothyroidism; Male; T | 1999 |
Amiodarone compared with iodine exhibits a potent and persistent inhibitory effect on TSH-stimulated cAMP production in vitro: a possible mechanism to explain amiodarone-induced hypothyroidism.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Biological Availability; Cell Line; CHO Cells; Cholera | 1999 |
Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Humans; Hypothyroidism; | 1999 |
The mysterious case of the lost pituitary: amiodarone-induced hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Male; Middle Aged; Myocardial Ischemia; | 2000 |
More on amiodarone-induced depression.
Topics: Amiodarone; Anti-Arrhythmia Agents; Depression; Humans; Hypothyroidism; Vasodilator Agents | 1999 |
Amiodarone toxicity in a patient with simultaneous involvement of cornea, thyroid gland, and lung.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cornea; Humans; Hypothyroidism; Lung; Male | 2000 |
[Follow-up of thyroid function in patient treated with amiodarone].
Topics: Aged; Amiodarone; Female; Humans; Hypothyroidism; Myocardial Ischemia; Thyroid Function Tests; Vasod | 2000 |
[Incidence and timing of thyroid dysfunction with long-term amiodarone therapy].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Drug Administration Schedule; Fe | 2001 |
Transient fetal hypothyroidism due to direct fetal administration of amiodarone for drug resistant fetal tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, N | 2001 |
Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Female; Follow-Up Studies; Humans; H | 2001 |
[Iatrogenic thyroid pathology].
Topics: Amiodarone; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Diseases | 1977 |
[Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Heart Block; Humans; Hypothyroidism; M | 1978 |
[Amiodarone and fetal supraventricular tachycardia. Apropos of a case with neonatal hypothyroidism].
Topics: Amiodarone; Female; Heart Rate, Fetal; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal Excha | 1992 |
Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
Topics: Amiodarone; Antibodies; Humans; Hypothyroidism; Male; Methimazole; Methylprednisolone; Middle Aged; | 1992 |
Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Iodine; Iodine Radioisotopes; Middle Aged; Perchlorates; | 1992 |
[Effects of amiodarone on the thyroid gland in euthyroid and hypothyroid animals].
Topics: Amiodarone; Animals; Guinea Pigs; Hypothyroidism; Male; Rats; Rats, Wistar; Thyroid Gland; Thyroid H | 1992 |
Outcome of thyroid function in newborns from mothers treated with amiodarone.
Topics: Adult; Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal Exchange; Pregnan | 1992 |
Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate.
Topics: Adult; Amiodarone; Atrial Flutter; Electrocardiography; Female; Humans; Hydrops Fetalis; Hypothyroid | 1992 |
Use of amiodarone during pregnancy.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Fetal Blood; Humans; Hypothyroidism; Infant, Newborn; Lact | 1992 |
[Hypothyroid coma probably related to amiodarone therapy: apropos of a case].
Topics: Aged; Aged, 80 and over; Amiodarone; Coma; Female; Humans; Hypothyroidism | 1992 |
[Neonatal hypothyroidism after amiodarone therapy during pregnancy].
Topics: Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Pregnancy; Pregnancy Complications; Pre | 1992 |
[Complications of low-dose amiodarone].
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Photosensitivity Disorders | 1991 |
Amiodarone antagonizes the effects of T3 at the receptor level: an additional mechanism for its in vivo hypothyroid-like effects.
Topics: Amiodarone; Animals; Body Weight; Hypothyroidism; Iodine Radioisotopes; Male; Myosins; Organ Size; P | 1991 |
Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Female; Follow-Up Studies; Humans; | 1991 |
Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Female; Goiter; Humans; Hypothyroidism; Middle Aged; Tachycardia, Supraventricular; Thyr | 1991 |
[Amiodarone-induced hypothyroidism revealed by lymphocytic ascites].
Topics: Aged; Amiodarone; Ascites; Female; Humans; Hypothyroidism | 1990 |
Amiodarone does not affect the distribution and fractional turnover of triiodothyronine from the plasma pool, but only its generation from thyroxine in extrathyroidal tissues.
Topics: Adult; Amiodarone; Female; Humans; Hypothyroidism; Male; Metabolic Clearance Rate; Middle Aged; Thyr | 1990 |
[Thyroid clinical dysfunction in patients chronically treated with amiodarone].
Topics: Adult; Aged; Amiodarone; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hyperthyroidism | 1990 |
Iodine induced thyroid disease.
Topics: Amiodarone; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Iodine | 1990 |
Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism.
Topics: Aged; Aged, 80 and over; Amiodarone; Female; Humans; Hypothyroidism; Male; Thyroid Hormones; Thyrotr | 1990 |
Amiodarone-induced changes in lipid metabolism.
Topics: Aged; Amiodarone; Apolipoproteins; Cholesterol; Female; Humans; Hypothyroidism; Lipid Metabolism; Li | 1990 |
Attenuation of class 3 and sinus node effects of amiodarone by experimental hypothyroidism.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Electrocardiography; Guinea Pigs; Hypothyroidism; Male; | 1989 |
24 h-kinetics of iodide uptake in amiodarone induced hypothyroidism.
Topics: Aged; Aged, 80 and over; Amiodarone; Biological Transport, Active; Female; Humans; Hypothyroidism; I | 1989 |
[Dysthyroidism caused by amiodarone. Frequency and diagnosis].
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Diseases; Thyrotropin; Thyroxine; Triio | 1989 |
[Transitory efficacy of potassium perchlorate in hypothyroidism caused by amiodarone].
Topics: Aged; Aged, 80 and over; Amiodarone; Female; Humans; Hypothyroidism; Perchlorates; Potassium; Potass | 1989 |
Acute necrotising myopathy associated with amiodarone therapy.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Humans; Hypothyroidism; Male; Muscles; Muscular | 1989 |
Amiodarone-related cyclic thyroid dysfunction.
Topics: Adolescent; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Male; Recurrence; Thyroiditis, Auto | 1989 |
Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination.
Topics: Adult; Aged; Amiodarone; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; | 1989 |
[Changes in the concentrations of thyroid hormones in a thyroidectomized patient undergoing treatment with levothyroxine and amiodarone].
Topics: Amiodarone; Drug Interactions; Humans; Hypothyroidism; Male; Middle Aged; Pituitary Gland, Anterior; | 1989 |
Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction.
Topics: Adult; Aged; Amiodarone; Female; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; Male | 1988 |
[Behavior of the cardiologist when faced with amiodarone-induced hormonal changes].
Topics: Adult; Amiodarone; Female; Glucocorticoids; Humans; Hyperthyroidism; Hypothyroidism; Male; Perchlora | 1988 |
Amiodarone and thyroid.
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism | 1987 |
Effects of amiodarone on thyroid hormone-responsive gene expression in rat liver.
Topics: Amiodarone; Animals; Cell Nucleus; Enzyme Induction; Gene Expression Regulation; Glutamate-Ammonia L | 1987 |
Myeloneuropathy, neurologic toxicity, and amiodarone.
Topics: Amiodarone; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Peripheral Nerv | 1985 |
Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Iodides; Iodine | 1985 |
Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hypothyroidism; Iodine; Iodine Radioisotopes; | 1986 |
Short term administration of potassium perchlorate restores euthyroidism in amiodarone iodine-induced hypothyroidism.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Humans; Hypothyroidism; Male; Middle Aged; Perch | 1986 |
Immunoradiometric assay of thyrotropin in plasma: its value in predicting response to thyroliberin stimulation and assessing thyroid function in amiodarone-treated patients.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Immunoassay; | 1986 |
[Amiodarone and thyroid function].
Topics: Adult; Aged; Amiodarone; Cardiovascular Diseases; Drug Administration Schedule; Female; Humans; Hype | 1987 |
Decreased TSH response to TRH induced by amiodarone.
Topics: Amiodarone; Humans; Hypothyroidism; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodoth | 1988 |
Effects of amiodarone therapy on thyroid iodine content as measured by x-ray fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; H | 1988 |
Noncardiac side-effects of long-term oral amiodarone in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Aspartate Aminotran | 1988 |
[Thyroid uptake of I131 in iodine-induced thyroid pathology caused by amiodarone].
Topics: Adult; Aged; Amiodarone; Female; Humans; Hyperthyroidism; Hypothyroidism; Iodine Radioisotopes; Male | 1988 |
Congenital hypothyroid goiter and amiodarone.
Topics: Adult; Amiodarone; Congenital Hypothyroidism; Female; Goiter; Humans; Hypothyroidism; Infant; Infant | 1988 |
[Hypothyroidism following maternal treatment with amiodarone].
Topics: Amiodarone; Female; Fetal Diseases; Heart Failure; Humans; Hypothyroidism; Infant, Newborn; Male; Ma | 1988 |
Amiodarone pharmacokinetics. III. Influence of thyroid dysfunction on amiodarone absorption and disposition.
Topics: Amiodarone; Animals; Biological Availability; Chromatography, High Pressure Liquid; Half-Life; Hyper | 1988 |
Amiodarone and thyroid hormone effects on anterior pituitary hormone gene expression.
Topics: Amiodarone; Animals; Cells, Cultured; Female; Genes; Hypothyroidism; Pituitary Gland, Anterior; Pitu | 1987 |
Effect of amiodarone on serum lipids, lipoprotein lipase, and hepatic triglyceride lipase.
Topics: Adipose Tissue; Amiodarone; Animals; Cholesterol; Hypothyroidism; Lipase; Lipids; Lipoprotein Lipase | 1987 |
Clinical significance of a low concentration of thyrotropin: five immunometric "kit" assays compared.
Topics: Adenoma; Adult; Amiodarone; Carbimazole; Depression; Female; Graves Disease; Humans; Hyperthyroidism | 1987 |
Severe hypothyroidism induced by amiodarone in a dialysis patient.
Topics: Amiodarone; Humans; Hypothyroidism; Male; Middle Aged; Renal Dialysis | 1987 |
[Amiodarone does not inhibit pituitary 5'-deiodinase activity in hypothyroid rats].
Topics: Amiodarone; Animals; Hyperthyroidism; Hypothyroidism; Iodide Peroxidase; Male; Pituitary Gland; Rats | 1987 |
Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Autoantibodies; Female; Follow-Up Studies; Humans; Hypot | 1987 |
Effects of amiodarone and thyroid dysfunction on myocardial calcium, serum calcium and thyroid hormones in the rat.
Topics: Amiodarone; Animals; Calcium; Hypothyroidism; In Vitro Techniques; Male; Muscle Proteins; Myocardium | 1987 |
Amiodarone therapy effects on childhood thyroid function.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Child; Chi | 1986 |
[Recurrent alveolitis caused by amiodarone].
Topics: Amiodarone; Benzofurans; Eye Diseases; Female; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; | 1986 |
Amiodarone-induced thyroid dysfunction: diagnostic role of free serum thyroid hormone levels and pathogenetic significance of antithyroid antibodies.
Topics: Adult; Aged; Amiodarone; Autoantibodies; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidis | 1986 |
Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat.
Topics: Amiodarone; Animals; Benzofurans; Hypothyroidism; In Vitro Techniques; Iodide Peroxidase; Liver; Mal | 1986 |
Amiodarone and thyroid hormone metabolism.
Topics: Amiodarone; Angina Pectoris; Female; Humans; Hypothyroidism; Iodine; Male; Thyroid Diseases; Thyroid | 1986 |
Thyroid dysfunction during chronic amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Female; Humans; Hyperthyroidism; Hypothyroidism | 1987 |
[Hyper and hypothyroidism induced by amiodarone].
Topics: Adult; Amiodarone; Female; Humans; Hyperthyroidism; Hypothyroidism; Imidazoles; Male; Middle Aged; P | 1986 |
Amiodarone-induced thyroid gland dysfunction.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Iodine; Male; Tachycardia; Thyroid Diseases; Thyroid Gla | 1987 |
Ascites during treatment with amiodarone.
Topics: Aged; Amiodarone; Ascites; Humans; Hypothyroidism; Male | 1987 |
[The thyroid and amiodarone (II). Thyroid dysfunction in patients undergoing prolonged treatment with amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Female; Heart Failure; Humans; Hyperthyroidism; Hy | 1985 |
Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block.
Topics: Amiodarone; Benzofurans; Bundle-Branch Block; Electrocardiography; Electrophysiology; Female; Heart | 1986 |
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; H | 1985 |
Amiodarone-associated hypothyroidism--a possible cause of digoxin intoxication.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Digoxin; Drug Interactions; Electrocardiography; Female; | 1985 |
Digoxin-amiodarone-hypothyroidism interaction.
Topics: Amiodarone; Benzofurans; Digoxin; Drug Interactions; Humans; Hypothyroidism | 1985 |
[Amiodarone and thyroid dysfunction].
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle | 1985 |
[Thyroid pathology iatrogenically induced by iodinated products].
Topics: Amiodarone; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Diseases; Thyroid Hormo | 1985 |
Amiodarone-induced dysthyroidism.
Topics: Amiodarone; Benzofurans; Coronary Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Age | 1985 |
[Hyper- or hypothyroidism in chronic treatment with amiodarone: a diagnostic and therapeutic dilemma].
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle | 1985 |